Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2020 / Article
Special Issue

Harmful and Beneficial Role of ROS 2020

View this Special Issue

Review Article | Open Access

Volume 2020 |Article ID 9829176 | https://doi.org/10.1155/2020/9829176

Sergio Di Meo, Paola Venditti, "Evolution of the Knowledge of Free Radicals and Other Oxidants", Oxidative Medicine and Cellular Longevity, vol. 2020, Article ID 9829176, 32 pages, 2020. https://doi.org/10.1155/2020/9829176

Evolution of the Knowledge of Free Radicals and Other Oxidants

Academic Editor: Marco Malaguti
Received03 Mar 2020
Accepted31 Mar 2020
Published24 Apr 2020


Free radicals are chemical species (atoms, molecules, or ions) containing one or more unpaired electrons in their external orbitals and generally display a remarkable reactivity. The evidence of their existence was obtained only at the beginning of the 20th century. Chemists gradually ascertained the involvement of free radicals in organic reactions and, in the middle of the 20th century, their production in biological systems. For several decades, free radicals were thought to cause exclusively damaging effects . This idea was mainly supported by the finding that oxygen free radicals readily react with all biological macromolecules inducing their oxidative modification and loss of function. Moreover, evidence was obtained that when, in the living organism, free radicals are not neutralized by systems of biochemical defences, many pathological conditions develop. However, after some time, it became clear that the living systems not only had adapted to the coexistence with free radicals but also developed methods to turn these toxic substances to their advantage by using them in critical physiological processes. Therefore, free radicals play a dual role in living systems: they are toxic by-products of aerobic metabolism, causing oxidative damage and tissue dysfunction, and serve as molecular signals activating beneficial stress responses. This discovery also changed the way we consider antioxidants. Their use is usually regarded as helpful to counteract the damaging effects of free radicals but sometimes is harmful as it can block adaptive responses induced by low levels of radicals.

1. Introduction

The term “radical” was first introduced by Guyton de Morveau in 1786 and later used by Gay-Lussac, Liebig, and Berzelius to indicate groups of atoms which were found unchanged in many substances (see Solov’ev [1]). The introduction of the term is generally attributed to Liebig and Wöhler, who in 1832 published a paper reporting that, in the various transformations of the essence of bitter almonds (the benzoic aldehyde) and of its derivatives containing chlorine and bromine, the radical, to which the formula C14H10O2 was attributed, remained unchanged [2]. The work of Liebig and Wöhler exercised a considerable influence on the development of organic chemistry. After the classification of organic compounds in homologous series, the radicals were considered as groups of atoms, belonging to molecules of organic compounds, which are kept unaltered in reactions involving the functional group of the compounds and which can be replaced by other radicals without modifying these reactions substantially.

Despite the interest in the radicals and their chemistry, their isolation was considered impossible, and, until the end of the nineteenth century, no direct evidence of their independent existence was found. In 1840, Berzelius believed that the inability to isolate the radicals did not depend on the fact that they did not exist but on the fact that they were combined too quickly and that the methods available in that time were insufficient for their isolation (see Solov’ev [1]).

Presumably, the first reaction involving free radicals was that of Fenton in 1894 [3]. He noted that when to a small amount of a tartaric acid solution a drop of diluted solution of ferrous sulphate was added, followed by a drop of hydrogen peroxide and finally an excess of caustic alkali, a light violet colour was obtained. The observed change was proposed as a distinguishing test for tartaric acid. Free radicals were not known at that time, and only three decades later, the involvement of the hydroxyl radical (OH) was proposed by Haber and Wilstätter [4]. Currently, oxidation processes that use H2O2 activation by iron salts, classically referred to as Fenton’s reagent, are known to be very effective in destroying many dangerous organic pollutants in water. Furthermore, the Fenton reaction plays a very important role in free radical biology and medicine.

However, the path taken to recognize the possibility of the independent existence of free radicals and their fundamental importance for living systems has been long and not without obstacles. This review is aimed at retracing this path by highlighting the steps that have made a fundamental contribution to understanding the role played by free radicals in biological systems (Table 1).

Toxic effects of oxygen on central nervous system (Paul Bert effect)Bert [61]
Pulmonary toxicity of oxygen (Lorrain Smith effect)Smith [62]
Preparation of the triphenylmethyl radical, (C6H5)3CGomberg [5]
Properties of xanthine oxidoreductase (XOR)Schardinger [100]
Oxygen effect on radiosensitivitySchwartz [44]
Isolation of the atomic hydrogenWood [11]
Preparation of the free radical methyl (CH3)Paneth and Hofeditz [13]
“Activated solvent” hypothesis for indirect action of ionizing radiationRisse [40]
Discovery of free radicals as biochemical intermediates in biological systemsMichaelis [29]
First utilization of X-rays for cancer treatmentGrubbe [218]
Discovery of the “peroxide effect”Kharasch and Mayo [14]
Generation of the hydroxyl radicalHaber and Weiss [27]
Suggestion of a link between retinopathy and excess of oxygenCampbell [64]
Involvement of free radical in oxygen toxicityGerschman et al. [68]
Observation of free radicals in biological systems by ESRCommoner et al. [69]
Detection by ESR of a semiquinone during the riboflavin oxide-reductionBeinert [31]
Implication of free radicals in biological agingHarman [70]
Formation of H2O2 by microsomal NADPH oxidaseGillette et al. [86]
Spin restriction in oxygen reactivityTaube [67]
Discovery of the superoxide dismutase (SOD)McCord and Fridovich [71]
“Superoxide theory” of oxygen toxicityMcCord et al. [74]
Generation of H2O2 by pigeon heart mitochondriaLoschen et al. [82]
Mitochondrial formation of H2O2 under hyperbaric conditionsBoveris and Chance [85]
Superoxide as initial product of respiratory burstBabior et al. [95]
H2O2 mimics the signaling activity of insulinCzech et al. [238]
Stimulation of NADPH oxidase by insulinMukherjee and Lynn [240]
Activation by OH radical of guanylate cyclaseMittal and Murad [237]
Oxygen radical involvement in reperfusion injuryGranger et al. [102]
Observation by ESR of ROS production during exerciseDavies et al. [199]
Formation of peroxynitrite from nitric oxide and superoxideBlough and Zafiriou [129]
Definition of “oxidative stress”Sies [157]
Increase in lipid peroxidation in hyperthyroid rat liverFernández et al. [181]
Identification of bacterial oxyR geneChristman et al. [260]
Identification of endothelial-derived relaxing factor (EDRF) in NOIgnarro et al. [121]; Khan and Furchgott [122]; Palmer et al. [123]
Purification of nitric oxide synthase (NOS)Bredt and Snyder [125]
Relationship between free radicals and muscle fatigueReid et al. [249]
Training slows down peroxidative processes during acute exerciseVenditti and Di Meo [331]
Discovery of Nrf2Itoh et al. [265]
Training decreased free radical activityVenditti et al. [337]
Mechanisms by which ROS initiate cellular signalingThannickal and Fanburg [295]
Antioxidant supplementation prevents training-induced useful adaptations for muscular cellsGomez-Cabrera et al. [339]
ROS generation promotes healthy agingRistow and Schmeisser [254]

2. Free Radical Isolation

Only at the beginning of the last century, evidence was found that isolation of organic free radicals with a measurable lifetime was possible following the preparation of the triphenylmethyl radical, (C6H5)3C, carried out by Gomberg [5].

In this compound, obtained during the attempt to synthesize the hydrocarbon hexaphenylethane, (C6H5)3-C-C-(C6H5)3, the central carbon is trivalent since it is combined with three substituents instead of four and presents an unshared electron. Free radicals of the triphenylmethyl type are stable only in certain organic solvents; they are rapidly destroyed by irreversible reactions in the presence of air, water, or strong acids.

A whole range of other aryl-substituted analogous compounds was prepared soon afterwards, and Gomberg’s inference that the hexaphenylethane dissociated into two free radicals was apparently substantiated by carrying out molecular weight determinations [6, 7].

It is interesting that this discovery involved stable free radicals. Generally, most free radicals are extremely reactive and, consequently, short-lived species. The great chemical reactivity of the free radicals is to be associated with the available combining energy of the odd electron and their reactions, whenever possible, resulting in the completion of electron pairs. The reason for the relative stability of triphenylmethyl and its analogues, which favoured their isolation, was not an easy problem to solve for theoretical chemists. However, the application of wave mechanics to organic chemistry led to an extended conception of resonance within complicated molecules, and it was realized that the domain of the odd electron of triphenylmethyl, like that of the aromatic sextet of benzene, may extend over a large region of intramolecular space. In consequence, much less intrinsic energy is associated with the free valence electron in the complex molecule of the triphenylmethyl than in more simple compounds. However, a relatively stable species, such as triphenylmethyl, is not commonly found, and the technology in that year could not handle transient entities with a very short life so that the research on free radicals had to await further developments.

In many quarters, Moses Gomberg’s announcement of the triaryl methyl type free radicals was greeted, even as late as 1930, with disbelief or, at least, disinterest. Still, in 1915, von Richter wrote: “The assumption of the existence of free radicals, capable of existing alone and playing a special role in chemical reactions, has long been abandoned” [8]. A decade later Porter, at Berkeley, said: “Negative results gradually established the doctrine that a free carbon radical was incapable of independent existence” [9], even though the evidence of the existence of free radicals continued to increase.

Although measurements of the vapour densities of gases at high temperatures had indicated that diatomic molecules could dissociate into free atoms, the possibility of the independent existence, at normal temperatures, of free atoms such as hydrogen, oxygen, or chlorine received almost no consideration until 1913, when Bohr showed that the spectrum emitted from a hydrogen discharge tube could be interpreted as an emission spectrum of an atomic form and not of a molecular form of hydrogen [10].

In 1922, Wood [11] first isolated and described the properties of atomic hydrogen, which he produced in an electrical discharge tube. The chemical properties of atomic hydrogen were investigated more fully by Bonhoeffer in 1924 [12].

Subsequently, Paneth and Hofeditz [13] prepared the free radical methyl (CH3), by pyrolysis of tetramethyl lead using an adaptation of the system used by Bonhoeffer to study atomic hydrogen.

In the subsequent years, the extensive and careful work of Gomberg and other authors who carried on in his field, together with the work on gas-phase free radicals initiated by Paneth, led to a body of experimental evidence for stable as well as short-lived free radicals, so that free radicals gained respectable status in chemical circles.

3. Free Radical in Chemical Reactions

Considering the significant progress made in the field of free radical isolation, it is not surprising that chemists would start to introduce free radical hypotheses into their reaction mechanisms. In 1933, Kharasch and Mayo [14] invoked a free radical mechanism for the addition of hydrogen bromide to olefins which was subsequently applied to other chemical systems.

Before 1933, the orientation of the addition of hydrogen bromide to alkenes was the subject of much confusion. Sometimes, the addition took place according to Markovnikow’s rule [15], which established that the acidic proton adds to the less substituted carbon of the double bond. This is because the carbocation obtained from this addition is stabilized by the presence of electron repellent alkyl group(s):

However, at other times, addition took place in the opposite way as the hydrogen added to the most substituted carbon. The mystery was solved in 1933 by the research of Kharasch and Mayo who explained how an anti-Markovnikow orientation could be achieved via free radical addition [14]. The factors able to explain this process turned out to be organic peroxides present in the alkenes-peroxides that were formed by the action of atmospheric oxygen on the alkenes. Indeed, Kharasch and Mayo found that when alkenes that contained peroxides or hydrogen peroxide reacted with hydrogen bromide, anti-Markownikoff addition of hydrogen bromide occurred. Thus, they proposed that the anti-Markownikoff addition of HBr was due to the presence of peroxides and termed this the “peroxide effect,” which was thought to proceed through a free radical chain addition reaction in which the intermediate carbon-centred radical was stabilized by the adjacent alkyl group(s):

Kharasch also suggested that radical intermediates and chain reactions can play an important role in many organic reactions, and over the following years, he succeeded in developing synthesis reactions, including sulfonation [16], chlorination [17], and carboxylation [18] of hydrocarbons and paraffin.

His work paved the way to the development of synthetic materials ranging from rubber to plastics. Conventional polymerization for condensation continued to be used to produce nylon and other products. But free radical polymerization had advantages such as high tolerance of chemical impurities and extreme temperatures and the ability to be used with a wide range of monomers (organic molecules). Today, free radicals are used to produce nearly half the polymers we use—materials used in everything from food wrapping to paint, adhesives, film, carpeting, piping, and more.

In this context, the work of Semenov, whose researches fall into the field of chemical kinetics and the processes of combustion, is significant [19]. The outcome of these researches is the certainty that many chemical reactions are aided by free radicals which are produced during the process. Semenov’s work also opened a new path for understanding the connection between the reactivity and the structure of particles entering a chemical reaction and created the possibility of rationally regulating the rate and direction of chemical changes. This, in turn, had profound consequences for the improvement of consolidated industrial processes and for the development of new processes, for example, in the fields of polymerization and direct oxidation as well as hydrocarbon cracking. Interestingly, some concepts of Semenov concerning chain reactions were also formulated by the renowned English kinetic chemist C. N. Hinshelwood [20], who was awarded the Nobel Prize in Chemistry jointly with Semenov in 1956 (Table 2).

Fritz Haber1918 ChemistryFor the ammonia synthesis process
Albert Szent-Györgyi1937 MedicineFor his discoveries on biological combustion processes, with particular reference to vitamin C and fumaric acid catalysis
Linus C. Pauling1954 ChemistryFor his researches in the field of the molecular attraction and its applications for the explanation of the structure of complex substances
Nikolaj N. Semënov1956 ChemistryFor his researches on mechanisms of chemical reactions
Cyril N Hinshelwood1956 ChemistryFor his researches on mechanisms of chemical reactions
Gerhard Herzberg1971 ChemistryFor his contributions to the knowledge of electronic structure and the geometry of molecules, in particular free radicals
Louis J Ignarro1998 MedicineFor the discovery of NO as signal molecule
Ferid Murad1998 MedicineFor the discovery of NO as signal molecule
Robert F. Furchgott1998 MedicineFor the discovery of NO as signal molecule

It is worth noting that antioxidants were used for the first time in the nineteenth century in the rubber industry when it was observed that some molecules, identified empirically, could slow the degradation and allow optimization of the process of vulcanization. Moureau and Dufraisse [21] were the first to propose an inclusive theory which should account for the effectiveness of almost infinitesimally small amounts of material in retarding or accelerating the processes of oxidation.

It has also been suggested [22] that Cummings and Mattill [23], who in 1931 realized the idea of the function of vitamin E as an in vivo lipid antioxidant, were perhaps inspired by the work on autoxidation by Moureau and Dufraisse [21].

In terms of antioxidants, a milestone in the evolution of knowledge was the work of Albert Szent-Györgyi, who, in the thirties, isolated a strongly reducing substance that he called “hexuronic acid” [24], and that was subsequently identified as vitamin C [25].

The same researcher and his collaborators studied the antioxidant effect of polyphenols found in plants governing vascular permeability and proposed the name vitamin P [26] but could not withstand the criticism of the absence of deficiency syndrome, as fundamental to the definition of a function vitamin.

A further significant contribution to the free radical chemistry was the concept found in Haber’s final paper [27] that the highly reactive hydroxyl radical could be generated from an interaction between superoxide (O2) and hydrogen peroxide (H2O2):

The authors recognized that the reaction is thermodynamically unfavourable in biologic systems, having a second-order rate constant of zero in aqueous solution, and would require some sort of catalyst to proceed. Thus, they discussed the need for a metal ion catalyst and illustrated that the net reaction creating the hydroxyl radical can be broken down into two chemical reactions (Equations (4) and (5)).

The former predicts that hydrogen peroxide is reduced at the iron centre with the generation of the hydroxyl free radical. This reaction is commonly referred to as Fenton reaction although Fenton never wrote it:

The second indicates that superoxide recycles oxidized iron to the ferrous form:

It is interesting that, although a lot of research was done to determine the nature of the species involved in Fenton reaction, the nature of these species is still under discussion. In fact, the popular theory, due to Haber-Weiss, involving the formation of OH radicals, has been questioned by studies suggesting an alternative interpretation of the Fenton reaction including the formation of the ferryl ion as active oxidizing species [28].

Chemical studies involving free radicals were ongoing for many years before it was recognized that such reactive species are produced in biological systems. At that point, it was quickly realized that the Haber-Weiss reaction might represent the major mechanism by which the highly reactive hydroxyl radical is generated in biological systems.

4. Free Radicals in Biological Systems

It is widely believed that the prolific work of Leonor Michaelis was responsible for the interest in free radicals as naturally occurring biochemical intermediates in biological systems. In investigations started in the 30s, Michaelis observed that the curves of oxidation-reduction potentials, obtained by adding increasing amounts of an oxidant to hydroquinone, initially showed the loss of an electron and then, in a subsequent stage, the loss of another electron [29]. He believed that the loss of the first electron corresponded to the formation of the free semiquinone radical. The second electron was given by the semiquinone with the formation of the completely oxidized form, the quinone.

Since the intermediate radicals are very unstable and quickly lose the second electron, their concentration in the reaction medium is very low, so it is very difficult, or even impossible, to identify them. Therefore, it is not always possible to differentiate oxidation reactions, which proceed in one step and involve radicals, from those that proceed by transferring two electrons at a time, relying exclusively on the products that are formed. However, Michaelis enunciated the theory that all the oxidations of organic molecules, which involve the exchange of two electrons, proceed through two successive stages, the intermediate stage being constituted by a free radical [30].

We know today that this theory is inaccurate in that there are biochemical reactions in oxidative reactions with loss of two electrons, which occur in a single step and which do not involve free radicals. However, Michaelis’s ideas gave rise to research that indicated that some intermediate reagent can sometimes be identified in enzymatic oxidation-reduction reactions of biological molecules, even though there was no evidence that the intermediate was a free radical.

However, starting in 1954, using sensitive methods for detecting free radicals, such as electronic spin resonance (ESR), which uses the paramagnetism of free radicals, some researchers showed that in some enzyme-substrate systems, it was possible to identify a paramagnetic intermediate compound. One of the areas in which the ESR was validly used was the study of enzymatic oxidation. In such reactions, an electron is first removed by an enzyme from the substrate and then transferred to a coenzyme. An important example is the formation of a semiquinone during the riboflavin oxide-reduction (vitamin B2), which constitutes the flavin coenzymes, flavin mononucleotide (FMN), and the flavin adenine dinucleotide, involved in many oxidation-reduction reactions [31].

Later, it was shown that free radicals were much more widespread in biological systems than previously assumed. Free radicals were found not only in the case of oxidation-reduction processes but also in many reactions of biological interest such as photochemical reactions, photosynthesis, and bioluminescence.

The path, which has led to the onset and acceptance by the scientific community of the idea that free radicals are continuously formed in the cell as collateral products of normal metabolic reactions, can be initiated by the discovery of the mechanisms underlying the effects of oxygen toxicity and ionizing radiation.

5. Effects of Radiation

Evidence is available that physical or chemical environmental perturbations, of which radiation emission is perhaps the main contributor, can induce pathological effects through free radical mechanisms.

In 1895, the German physicist Röentgen discovered “a new kind of ray” which could blacken photographic films enclosed in a light-tight box [32]. He named these rays as X-rays, which meant unknown rays. In 1896, radioactivity was discovered by Antoine Henri Becquerel [33]. In the same year, Pierre and Marie Curie discovered and isolated radium successfully [34].

The potential hazards of radiations or radioactive materials were not adequately acknowledged at the beginning of their discoveries, although there was evidence that radiation produces biological damage. In fact, the first cases of human injury were reported in the literature just a few months following Röentgen’s original paper announcing the discovery of X-rays (see Sansare et al. [35] for a review). Furthermore, as early as 1904, the first case of death occurred due to metastatic carcinoma induced by X-ray exposure.

Early human evidence of harmful effects because of exposure to radiation in large amounts existed in the 1920s and 30s, based upon the experience of early radiologists, miners exposed to airborne radioactivity underground, persons working in the radium industry, and other special occupational groups. However, the long-term biological significance of smaller, repeated doses of radiation, however, was not widely appreciated until relatively recently, and most of our knowledge of the biological effects of radiation has been accumulated since World War II. In fact, much of what we know today about the relationship between ionizing and cancer stems from studies conducted on people who survived the atomic bombs of Hiroshima and Nagasaki. Since these were very particular exposure conditions, it was difficult for a long time to understand whether those conclusions could be applied even at the most common levels of exposure. In recent years, several studies have confirmed that even low levels of exposure can give rise to the transformation of cells that leads to the development of cancer. The quantification of this risk, however, is very complex: it depends on several factors, including the dose to which one is exposed and the duration of exposure, the type of radiation, the areas of the body irradiated, and the age at which one has entered in contact with radiation.

In the first part of the last century, much progress was also made in understanding the effects induced by ionizing radiation on individual components of biological systems and the basic mechanism underlying such effects.

Early studies concerning the action of radiation on enzymes had led to the conclusion that X- and γ-rays only influence enzymes when the dose is enormous [36]. However, in 1940, Dale found that the reason for these failures was the use of large amounts of enzyme and of impure preparations [37]. Indeed, by decreasing the concentration of the enzyme, the carboxypeptidase, he obtained inhibition with relatively low doses of X-rays. Subsequent studies showed that when dilute solutions of enzymes were irradiated with X-rays, the enzymes requiring -SH groups for enzymatic activity were more susceptible to inhibition than enzymes that did not require –SH groups for activity [38]. Furthermore, the enzymes can be reactivated by the addition of glutathione. Thus, it was suggested that inhibition of sulfhydryl enzymes was due to oxidation of sulfhydryl groups, whereas inhibition of nonsulfhydryl enzymes, which required larger amounts of X-rays, was attributed to protein denaturation. The mechanism of –SH groups was explained by following Weiss’s suggestion [39], of the liberation of free radicals resulting from the interaction of X-rays with the water molecules. In fact, ionizing radiation can directly damage different biologically essential macromolecules, such as DNA, membrane lipids, and proteins, through ionizations that create sites of electron loss (radical cations), electron gain (radical anions), and excitations. However, the action of ionizing radiation can also be indirect involving the primary formation of free radicals, such as H and OH, with subsequent formation of H2O2, atomic oxygen, and HO2, which react with the macromolecules.

This indirect action already suggested by Risse [40] in his “activated solvent” hypothesis, and later developed by Fricke [41], had been resumed by Dale, who had postulated that carboxypeptidase enzyme molecules were not directly affected by the ionizing radiation, but indirectly through collision with a labile product resulting from water ionization [31].

The significant consequences of various types of radiation-induced DNA damages show that DNA is the principal target for the biological effects of radiation.

In the early days, radiation-induced DNA damages were studied under two different conditions, irradiating the DNA molecule either directly or in a dilute aqueous solution. These studies allowed to establish that, as for proteins, ionizing radiation damages DNA either directly by deposition of energy in the DNA resulting in the ejection of electrons leading to the formation of a free radical (R) or indirectly by the ionization leading to the formation of hydroxyl radicals and indirectly by reactions with radicals produced by ionizing H2O molecules.

It was also hypothesized that the free radical-mediated covalent modifications leading to oxidative damage to critical biomolecules during and immediately following irradiation result in most, if not all, of the biological effects of ionizing radiation. The most compelling evidence in favour of this hypothesis came from observations that manipulations of antioxidants (i.e., thiols, hydroxyl radical scavengers, and hydroperoxide metabolizing enzyme systems) at the time of irradiation appeared to alter the reactions of free radicals (and reactive oxygen species) leading to alterations in oxidative damage as well as alterations in the biological effects of IR [38, 42, 43].

It is worth noting that the radiosensitivity of the tissues is strongly dependent on oxygen concentration, a phenomenon named oxygen effect. This effect was first demonstrated by Schwartz in 1909 [44]. Using X- and γ-rays, he showed that firm pressure applied to the skin during irradiation greatly reduced the subsequent reaction as compared to irradiation under normal conditions. Later, Jolly found reduced damage in the guinea pig and rat thymus irradiated when the blood supply was occluded by a ligature [45], and Mottram observed similar protection from radiation damage by occluding the blood supply of the rat’s tail by ligature of the vascular connections [46]. These findings were later confirmed by other researchers who used different animal species and tissues [47].

For a long time, the oxygen fixation hypothesis, developed in the late 1950s, has been widely regarded as the most satisfactory explanation of the oxygen effect [48]. Central to this hypothesis was the belief that most DNA damage produced by X-rays can be repaired, but that repair is more difficult or impossible when caused by the product of a radical and an oxygen molecule, so that the amount of stable DNA damage and the extent of lethality from a given dose increase [48]. In fact, the actual role of oxygen in the inactivation mechanism represents still an open problem; in particular, it has been shown that oxygen fixation hypothesis cannot be regarded as maintainable more and, on the other hand, has argued that the oxygen effect can be hardly a simple consequence of greater reactivity of oxygen radicals [49]. Such an explanation of the oxygen effect is based on the possibility that the primary radicals, H and react with O2, generating HO2 and O2⋅-, respectively:

This should lead to the generation of new free radicals which amplify the radiation effect. On the other hand, it is not possible to exclude that a free radical generated from a biological molecule, by direct effect or by extraction of one hydrogen by OH, can bind to O2 forming a peroxyl radical, which can fix the damage in a relatively unrepairable condition, and extract one hydrogen from another molecule causing a chain reaction.

It is also worth noting that, while classical radiation toxicity models identify DNA damage as the universal critical lesion in cells [50], studies now support that the survival of many organisms is governed by the level of oxidative protein damage caused during irradiation [51, 52], which limits the functionality and efficiency of enzymes, including those needed to repair and replicate DNA.

The presence of oxygen also increases the damage to lipids. Indeed, unsaturated lipids are liable to undergo a process known as lipid peroxidation, a chain reaction, initiated by reactive free radicals such as OH, which, in the presence of oxygen, leads to the formation of lipid peroxides and other derivatives [53]. Peroxidation of membrane lipids alters their structure and interferes with membrane function. Studies beginning in the 1960s showed that several halogenated hydrocarbons exert their toxic effects by stimulating lipid peroxidation and gave early emphasis on the biological role of free radical reactions [5456]. However, although detection of end products of lipid peroxidation is the evidence more frequently quoted for a role of free radicals in human disease or tissue injury by toxins, lipid peroxidation has not been well exploited to understand the biological effects of radiation. Probably, this occurred because increases in protein and DNA damage are often more important events in causing cell injury than peroxidation of membrane lipids, which is often a late event accompanying rather than causing final cell death.

6. Oxygen Toxicity

For a large part of living beings, oxygen is an essential molecule for survival, being the basis of biological oxidations, which meet most of the energy needs of aerobic organisms. Although oxygen is essential for these organisms, it can also act as a toxic agent and pose a threat to their existence. This contradictory aspect of aerobic life was defined by Davies as the “paradox of aerobic life” [57]. All organisms can survive in the presence of oxygen because, in adapting to the oxidizing atmosphere of the earth, they have developed an elaborate antioxidant defence system. However, this system is only suitable for oxygen pressure in the atmosphere (about 156 mmHg), and it is widely demonstrated that exposure to oxygen pressures greater than the atmospheric one causes severe damage.

Historically, reports of harmful effects of oxygen followed soon after the discovery and purification of the gas in the late 18th century, which permitted scientists to expose animals to oxygen-enriched atmospheres.

Usually, priority in the discovery of oxygen is given to Priestley who called it “dephlogisticated air” [58], even though the oxygen had been discovered in 1772 by Carl W. Scheele, a Swedish apothecary, who, however, did not publish his findings until 1777 [59].

Anyway, Priestley was one of the first to suggest that there may be adverse effects of this “pure air” when he observed a candle burn out faster in oxygen than in air and wondered if “the animal powers are too soon exhausted in this pure kind of air” [58].

On the other hand, the toxicity of atmospheric oxygen had already been exploited by our ancestors for therapeutic purposes, such as the treatment, by exposure to air, of sites infected with anaerobic bacteria.

Immediately after the promulgation of the combustion theory of respiration, the pertinent literature recorded a considerable number of investigations in connection with the question of oxygen toxicity. According to various authors, definite effects were obtained by breathing pure oxygen. The respiratory exchange was increased, the circulation quickened, and congestion of the lungs, or even inflammation and death, occurred. The theory was that the addition of oxygen increased the pulmonary combustion and thereby produced these pathological changes. This result was controverted by Regnault and Reiset in their classical investigation [60]. They showed that no increase in oxidation occurred and no pathological changes ensued on the exposure of animals to atmospheres rich in oxygen.

The first important contribution in the field of oxygen toxicity was by Paul Bert who, in 1878, first demonstrated convulsions in larks exposed to 15-20 ATA (atmosphere absolute) air [61], and the toxic effects of oxygen on the central nervous system are hence called “Paul Bert effect.” Furthermore, in a large series of experiments, he showed that the effects on all living organisms arising from variations in barometric pressure are entirely the result of the tensions at which the oxygen is maintained in the various atmospheres. By exposing an animal to four atmospheres of oxygen, the same effect is brought about as that caused by increasing the barometric pressure of the air 20 times [61].

In 1899, J Lorain Smith, while trying to reproduce “Bert effect,” noticed fatal pneumonia in rats after 4 days of exposure to 73% oxygen at 1 ATA [62]. This marked the discovery of pulmonary toxicity of oxygen, called the “Lorrain Smith effect.”

The signs of oxygen toxicity are detectable in various tissues, even if the most worrying ones are those of the central nervous system and of the lung, which can be considered real target organs.

However, when after 1940 the spread of a syndrome currently called “retinopathy of prematurity” was found in preterm infants, this syndrome was not related to oxygen toxicity. Retinopathy was characterized by the formation of new abnormal blood vessels in the retinal periphery and could result in real blindness due to retinal detachment. Furthermore, the lower the gestation time and the weight of the newborn at birth, the greater the risk. Retinopathy initially described as retrolental fibroplasia by Terry in 1942 [63] was the leading cause of blindness in children in the United States. Only in 1951, it was suggested that the retinopathy was due to an excess of oxygen in the incubators where premature infants were placed to promote their development [64].

6.1. Mechanisms of Oxygen Toxicity

The first hypothesis made to explain the toxic effects of oxygen was that it inhibits cellular enzymes. There were several examples of enzymatic inactivation linked to oxygen in anaerobic organisms [65]. However, there was a reluctance to conclude that the inhibitory effects of oxygen on metabolism were the direct cause of the symptoms of the oxygen toxicity on the intact animal.

Haugaard, who reviewed the pertinent literature in 1968 [66], gave two reasons why the hypothesis did not gain wider acceptance. First, the rates at which enzymes were inactivated in vitro were too slow to account for the rapidity of toxic effects in intact animals. Furthermore, in aerobic cells, most of the enzymes are completely insensitive to oxygen, and those inactivated are quite low.

Despite being a free radical, O2 does not present a high reactivity. The reactions in which it is involved do not normally occur at ordinary temperatures or in the absence of catalysts, although its high oxidizing power makes most of the substances of biological interest thermodynamically unstable in its presence. This apparent contradiction is explained by the electronic configuration of the O2 in the ground state, which has two electrons with parallel spins in the two outermost orbitals. For this reason, in the oxidation processes, it would be necessary to make available, by the molecules to be oxidized, two electrons with spin parallel to each other and opposite those of the unpaired electrons of oxygen. Since the molecules of stable organic compounds contain valence electrons with opposite spin, the need to operate spin inversion before electrons are accepted in the oxygen orbitals slows or precludes the reaction with such molecules, a phenomenon called spin restriction [67].

Since the energy necessary for vital processes in aerobic organisms derives from oxidation reactions in which oxygen is consumed, it is evident that in such organisms, processes are working through which the spin restriction is, in some way, eliminated with consequent increase of the reactivity of oxygen.

It is possible to put enough energy into oxygen to elevate one of its parallel spinning electrons to a higher orbital and in the process to invert its spin. Such an excited state of oxygen is referred to as singlet oxygen, and for singlet oxygen, the spin restriction has been eliminated and it is much more reactive than is ground state oxygen [67].

The energy inherent in visible light is enough to convert ground state oxygen into singlet oxygen, but oxygen does not absorb visible light. Dyes such as methylene blue or rose Bengal do absorb visible light and then, upon collision with oxygen, can transfer the energy from that light to oxygen. That is one basis of photosensitized oxidations. There is a way that the spin restriction can be circumvented, and that is by adding the electrons to oxygen one at a time at a rate that allows electronic spin inversions to occur between collisional events. The univalent pathway of oxygen reduction requires that intermediates of oxygen reduction be generated, which are reactive and can damage biological molecules.

On this basis, an important turning point in understanding the mechanism of toxicity occurred when in 1954 Gerschman and associates published an article hypothesizing that oxygen poisoning and radiation injury have at least one common basis of action, possibly through the formation of oxidizing free radicals [68]. The hypothesis was based on similarities of the effects of irradiation and exposure to hyperbaric oxygen, on the synergism between radiation and hyperbaric O2 in decreasing the survival of exposed mice, and on observations that substances of varied chemical nature known to increase resistance to irradiation exhibited protective action against oxygen poisoning.

In the same year, Commoner et al. made the first observation of free radicals in biological systems using electron paramagnetic resonance methods [69].

Two years later, Harman hypothesized that oxygen radicals may be formed as by-products of enzymatic reactions in vivo. He proposed that traces of iron would catalyse oxidative reactions in vivo and that peroxidative chain reactions were possible by analogy to the principle of in vitro polymer chemistry. Harman also implicated that free radicals are produced during aerobic respiration in cellular damage, mutagenesis, cancer, and degenerative process of biological aging [70].

The theory then led to a significant corollary on the role of antioxidants: if the oxidative reactions are a chain, one molecule that intercepts the radical initiator or propagator prevents the entire chain. It follows that only the reactions of radicals that trigger chains may be the subject of a functionally valid inhibition by antioxidants: a concept that, although simple, is today very often forgotten.

7. The Superoxide Dismutase Discovery

Harman’s idea did not capture the imagination of most life scientists, until the discovery of the superoxide dismutase (SOD) enzyme by McCord and Fridovich [71]. Toward the end of the 60s, these authors investigated the oxygen-dependent reduction of cytochrome c by xanthine oxidase [72]. Oxygen would be expected to oxidize cytochrome c rather than to facilitate reduction, so that McCord and Fridovich suggested that xanthine generated an unstable reduced form of oxygen, presumably the superoxide anion, and that this radical was the agent which directly reduced cytochrome c. Because some proteins inhibited the reduction of cytochrome c by xanthine oxidase, they realized that inhibitory effects were due to novel protein contaminating the other proteins tested, which catalysed the superoxide dismutation. They purified from bovine erythrocytes a protein that inhibited the reduction of cytochrome c. This protein had been previously purified as a copper-binding protein [73], but McCord and Fridovich showed that this protein was an efficient scavenger of superoxide, thus identifying the first enzyme known to act on a free radical substrate [71].

Similar enzymes were soon recovered from a wide range of air-tolerant bacteria but, significantly, were scarce in anaerobes [74].

A protein antioxidant catalyst which had as its substrate a small inorganic free radical was something novel to biochemistry at that time, but, paradoxically, the observation of the widespread distribution of SOD family of enzymes in cells was the major hint of the wide occurrence of free radical activity in the body.

Despite this, initially, the role of SOD was greeted with scepticism by some. Not all were prepared to accept that SOD was exclusively a biological enzyme and preferred to view it more as a copper transport protein.

In these conflicting opinions, an important role played the idea that the radicals were too reactive and uncontrollable to participate in any reaction involving an enzyme.

However, the discovery of the superoxide dismutase made real the existence of radicals in living systems and led to the “superoxide theory,” which foresaw that the O2 toxicity was due to the generation of anion radical superoxide [74]. Interestingly, subsequent observations performed modifying SOD activity showed that superoxide was at least partially responsible for the mechanisms leading to the well-known effects of oxygen on radiosensitization [75].

Subsequent studies showed that the superoxide is a moderately reactive radical, which under physiological conditions generally behaves as a mild reductant rather than an oxidizing agent. This is because superoxide exists naturally as a small anion, which is more prone to give its electron than to accept a second electron from another biological molecule. The limited chemical reactivity of superoxide created considerable controversy about the role of superoxide in cellular toxicity [76].

However, superoxide can be considered the “primary” oxidant species, whose generation can lead to the formation of more reactive “secondary oxidant species” [77].

To explain how a more potent oxidant might be generated by superoxide, the iron-catalysed formation of hydroxyl radical from hydrogen peroxide was proposed. Indeed, superoxide can undergo SOD-catalysed dismutation, producing hydrogen peroxide:

Hydrogen peroxide reactivity is reduced by the stability of its oxygen-oxygen bond. However, in the presence of reduced transition metals (e.g., Fe2+ or Cu+), it can be converted into the hydroxyl radical (Fenton reaction) (Equation (4)). Conversely, the hydroxyl radical has high reactivity, which makes it a very dangerous radical with a very short in vivo half-life of approx. 10−9 s [78].

The hydroxyl radical oxidizes most organic molecules at diffusion-limited rates, but its most significant impact is likely to be upon DNA since even a single DNA lesion is potentially mutagenic or lethal.

Because of its strong oxidant capacity and importance in radiation-induced damage to biological molecules, hydroxyl radical became widely accepted as the major toxin produced in vivo.

In the last quarter of the 20th century, the scientific community began to accept the fundamental principle that many of the same free radicals that were formed as a result of ionizing radiation interacting with biological material were also formed as by-products of oxidative metabolism.

8. Reactive Oxygen Species

It is worth noting that until the mid-1970s, the literature almost exclusively refers to free radicals. Later, it became evident that not only free radicals but also nonradical products, such as H2O2 or hypochlorous acid (HOCl), which are also powerful oxidizing agents, participate in free radical reactions. To consider both the radical and the nonradical species, the more general term “reactive oxygen species” (ROS) was introduced [79]. Later, species containing nitrogen, such as nitric oxide (NO) and peroxynitrite (ONOO-), were shown to be biological molecules and were termed reactive nitrogen species (RNS) [80].

This view that ROS were generated in biological systems was also supported by the finding of the cellular sources of such species. A mitochondrial H2O2 production had been first observed in 1966 by Jensen, who found that antimycin-insensitive oxidation of nicotinamide adenine dinucleotide (NADH) and succinate by bovine heart submitochondrial particle was coupled with H2O2 production [81]. Soon after, it was demonstrated, for the first time, that under aerobic condition, H2O2 was generated by pigeon heart mitochondria in the presence of succinate [82]. The discovery that mitochondria contain their own SOD, MnSOD [83], and the subsequent detection of the mitochondrial generation of superoxide radical anion [84] confirmed that H2O2 generated within mitochondria arose from the dismutation of superoxide (O2⋅−) and the biological significance of mitochondrial O2⋅− production. Since then, a huge literature has developed on the sources and consequences of mitochondrial production of reactive oxygen species. In particular, the discovery that electron transfer along the inner mitochondrial membrane carriers is associated with the formation of reactive oxygen species suggested the mitochondrial involvement in degenerative processes linked to several diseases and aging.

In this regard, it is worth noting that a detailed study evaluating the variations of formation of H2O2 under different metabolic conditions showed a marked increase in such a formation and its immediate onset under hyperbaric conditions [85], thus providing an explanation at the molecular level for “O2 poisoning.”

Although mitochondria are responsible for the continuous production of reactive oxygen species, they are not the only source at either the organism or the cellular level. In fact, in the 70s, evidence was already available that generation of active oxygen species can also occur as a by-product of other biological reactions in other cellular organelles.

For example, it was long known that liver microsomes contained an enzyme system, NADPH (TPNH) oxidase, which catalyses the oxidation of NADPH by oxygen to yield NAD+ and hydrogen peroxide [86]. In later years, this result was confirmed repeatedly, and the H2O2 formation was believed to be linked to the monooxygenation system for xenobiotics since pretreatment of the animals with phenobarbital increased the rate of H2O2 formation [87] and inhibitors of cytochrome P450 affected the production of H2O2 [88].

It was also recognized that NADPH-dependent redox chain of microsomes generated hydrogen peroxide and superoxide radicals [89], the latter being possibly precursors of the former. Moreover, superoxide formation involved autooxidation of NADP-specific flavoprotein dehydrogenase (NADPH-cytochrome c reductase) [88] and dissociation of oxycomplex of cytochrome P450 [90].

Other examples of cellular organelles which were found to have high oxidative activity include peroxisomes, which contain oxidases, which reduce oxygen to hydrogen peroxide at the expense of the oxidation of a substrate RH2, and large amounts of catalase (CAT), an enzyme able to reduce hydrogen peroxide to water [91]. The idea that the peroxisomes generate ROS as an integral feature of their normal metabolism was further exemplified by the fact that peroxisomes in the rat liver may be responsible for as much as 20% of the oxygen consumption and 35% of the H2O2 production [92].

In 1961, Iyer et al. [93] had shown that the phagocyte respiratory burst results in the generation of hydrogen peroxide; in 1964, Rossi and Zatti [94] had correctly proposed that an NADPH oxidase was responsible for the respiratory burst; and in 1973, Babior et al. [95] reported that the initial product of the respiratory burst oxidase was superoxide and not hydrogen peroxide. The phagocyte NADPH oxidase was the first identified example of a system that generates ROS not as a by-product but rather as the primary function of the enzyme system.

The next steps were the identification of proteins responsible for ROS production in phagocytes [96] and the cloning of the gene coding for the catalytic subunit of the phagocyte NADPH oxidase, commonly referred to as gp91phox [97], which in the novel NOX terminology was called NOX2. In parallel with the progress toward understanding the phagocyte NADPH oxidase, a series of observations suggested that enzyme systems like the phagocyte NADPH oxidase exist in many other cell types (see Bedard and Krause [98] for a review).

Several soluble cell components, including thiols, hydroquinones, catecholamines, and flavins, were found to be able to undergo redox reactions and contribute to intracellular ROS production [99]. To these, it occurs to add several cytosolic enzymes that produce ROS during their catalytic activity. Among the enzymes producing ROS, the researchers paid close attention to xanthine oxidase (XOR).

XOR is a flavoenzyme, which was extensively studied for its biochemical and structural properties ever since 1902 [100]. The enzyme catalyses the oxidation of hypoxanthine to xanthine and xanthine to uric acid using NADP+ or O2 as an electron acceptor. The mammalian enzymes exist in the NAD+-dependent form (xanthine dehydrogenase (XDH)) in freshly prepared samples from organs under normal conditions, i.e., they exhibit high xanthine/NAD+ reductase activity, even in the presence of O2 [101]. In oxidatively damaged tissues, the XDH is converted, due to proteolysis or oxidation of the thiol groups of cysteine, into xanthine oxidase (XO) [101], which, when acting on its substrates, is able to transfer electrons to molecular oxygen generating the superoxide [72].

Some years after, it was proposed that xanthine oxidase-derived oxidants mediate the microvascular injury associated with reperfusion of the ischemic intestine [102], and subsequently, this idea was extended to several organs and systems [103].

9. Reactive Nitrogen Species

The discussions above have focused on oxygen and oxygen-derived species. However, there are other relevant radicals, nitric oxide, NO, and its derivatives.

Nitric oxide is the first gaseous species unequivocally identified as an endogenously generated cell signalling/effector agent. Furthermore, superoxide is considered the primary ROS from which more strongly oxidizing species originate, so nitric oxide is considered the primary RNS.

Nitric oxide, first identified as a gas by Joseph Priestley, is a simple molecule consisting of just one atom of oxygen and one atom of nitrogen [104]. For a long time after this discovery, NO was thought to be simply an atmospheric pollutant. It is produced above all during high-temperature combustion processes, like those that happen in the engines of cars, together with nitrogen dioxide (NO2), another free radical. It is then oxidized in the atmosphere by oxygen and more rapidly by ozone-producing nitrogen dioxide. The toxicity of nitrogen dioxide is significant, contrary to that of nitric oxide, which is instead limited. Indeed, nitrogen dioxide plays a fundamental role in the formation of photochemical smog as it is the basic intermediate to produce a whole series of very dangerous secondary pollutants such as ozone, nitric acid, nitrous acid, alkyl nitrate, and peroxyacetyl nitrates.

The proposal that NO was a biological molecule was rather controversial because early indications of its presence in biological systems were ignored for many decades and even because nitrovasodilators had been used clinically for a century without understanding their mechanism of action. In fact, at that time, drugs such as nitroglycerine were given to patients for heart conditions like angina to promote vasodilation and reduce blood pressure, but no one knew how these drugs worked.

The discovery of NO as a biological molecule involved in vasodilation is linked to the studies dealing with cyclic guanosine monophosphate (cGMP) and endothelial-derived relaxing factor (EDRF).

Cyclic GMP began to emerge as a second messenger during the late 1960s and early 1970s. The existence of endogenously produced cGMP was demonstrated by its isolation and identification from rabbit urine [105]. Later, this was confirmed by another study from the same laboratory [106], which suggested that cGMP is synthesized in a reaction catalysed by a cyclase. In 1966, a phosphodiesterase specific for cGMP was isolated and partially purified from a dog heart [107], and subsequently, guanylyl cyclase activity was described [108]. Thus, it became apparent that steady-state levels of cGMP in cells and tissues were determined by the balance of cGMP synthesis by guanylyl cyclase and cGMP degradation by phosphodiesterases. Increased levels of cGMP produced by guanylate cyclase within vascular smooth muscle allowed blood vessels to relax and thus increase blood flow.

In 1977, two groups demonstrated independently that organic nitrates induced a dose-dependent increase in the levels of cGMP in smooth muscle [109, 110]. Subsequently, biochemical experiments showed that all the nitrovasodilators and nitric oxide (NO) activate the soluble guanylate cyclase [111, 112]. However, the possibility that NO might be synthesized in mammals and was able to function as an endogenous regulator was considered to be too far-fetched for another decade.

Progress was made when Furchgott and Zawadzki [113] found that without the endothelial cells the smooth muscle cells were not able to cause vasodilation. This suggested that a factor produced by the endothelial cells was required for relaxation of the blood vessels acting on an unidentified target in skeletal muscle. The diffusible factor later referred to as the endothelium-derived relaxing factor (EDRF) [114] was quickly inactivated by oxyhaemoglobin and was inherently unstable in the perfusion cascades used to study the vasorelaxation. It was soon shown that this mysterious factor, termed endothelial-derived relaxing factor (EDRF), increased cGMP synthesis in isolated blood vessels and increased protein phosphorylation in smooth muscle [115, 116].

Widespread speculation about the chemical nature of EDRF developed soon after its discovery [117, 118], but only in 1988, Furchgott [119] and Ignarro et al. [120] independently in papers presented at a symposium in Rochester, suggesting that EDRF produced by endothelium may be NO.

Soon after the 1986 symposium, three laboratories compared the biological and chemical characteristics of EDRF and NO, and all found EDRF released upstream and NO infused upstream to have similar rates of decay, similar susceptibility to inhibitors like Hb and superoxide generators, and similar stabilization by SOD [121123]. A year later, Palmer and coworkers [124] made the major finding that the source of endothelial NO was guanidinium hydrogen of L-arginine.

In 1990, Bredt and Snyder purified oxide nitric synthase (NOS), the enzyme responsible for NO synthesis from a rat cerebellum (NOS) [125]. Because this NOS was from the rat cerebellum, it was named the neuronal NOS isoform (nNOS or NOS-1). The discovery of constitutively expressed neuronal NOS was quickly followed by the identification of endothelium-derived NOS (eNOS or NOS-3), constitutively expressed [126], and inducible NOS (iNOS or NOS-2) not constitutively expressed [127].

The discovery of NO as an enzymatically generated free radical was paralleled by the recognition that it could readily react with O2⋅- [128]. It was known that the combination reaction leads to proximities [129], a peroxy acid originally studied in the chemical literature as a strong oxidizing and nitrating compound [130]. A paper on the unusual properties of a mixture of hydrogen peroxide and nitrous acid by Baeyer and Villiger from 1901 [131] can be regarded as the first report on peroxynitrite. However, as an oxidant, peroxynitrite attracted little attention because it produced a bewildering array of products even with simple starting substrates such as phenol. In 1970, several investigators more thoroughly characterized the chemistry of peroxynitrite showing that it decomposed to form hydroxyl radical and nitrogen dioxide [132].

At the end of the 80s, when NO was discovered, the controversy about the reactivity of superoxide and its biological effects was still open. Therefore, it is not surprising that NO was viewed by some researchers as a protective factor because of its capacity to scavenge radical superoxide thus acting as an antioxidant [133, 134]. However, in 1990, Beckman et al. suggested that the reaction product of superoxide and nitric oxide was peroxynitrite, which decomposes when protonated to form the potent oxidants, hydroxyl radical and nitrogen dioxide [135]:

These results were confirmed by Darley-Usmar and collaborators [136] using systems to cogenerate superoxide and NO.

The reaction of NO with O2⋅- occurs biologically even in the presence of superoxide dismutase (SOD), indicating that it is extremely fast to outcompete the enzyme-catalysed dismutation. Thus, nitric oxide may substantially increase the toxicity of superoxide converting a relatively mild reductant into at least two potent oxidants. The recognition that the homolysis of ONOOH could yield OH led to the postulation of a new biologically relevant mechanism of oxygen radical-mediated molecular damage, which is more effective than the widely accepted reaction of reduced iron with hydrogen peroxide (known as the Fenton reaction or the iron-catalysed Haber-Weiss reaction).

On the other hand, although Fenton chemistry was known to occur in vitro, its significance under physiological conditions was and remains a matter of debate today, noting particularly the negligible availability of “free catalytic iron” due to its effective sequestration by the various metal-binding proteins. However, organisms overloaded with iron (as in the conditions of haemochromatosis, β-thalassemia, and haemodialysis) contain higher amounts of “free available iron”, and this can have deleterious effects.

10. Oxidative and Nitrosative Damage

In the last quarter of the 20th century, following the discovery of the superoxide dismutase enzymes by McCord and Fridovich [71], the scientific community began to accept the fundamental principle that free radicals were formed as by-products of oxidative metabolism When ROS were initially integrated into biomedical concepts, it was thought that they caused exclusively toxic effects and were associated with pathologies. In fact, ROS avidly interact with many molecules including other small inorganic molecules as well as proteins, lipids, carbohydrates, and nucleic acids. Through such interactions, ROS may irreversibly destroy or alter the function of the target molecule.

Moreover, after its early description as an endothelial-derived relaxing factor, NO emerged not only as a fundamental signalling device but also as a potent mediator of cellular damage in a wide range of conditions, and nitrosative stress has been implicated in the pathogenesis of a large variety of disorders.

Although NO has often been described as highly toxic and reactive, it is not, and most of the cytotoxicity attributed to NO is rather due to peroxynitrite produced from the diffusion-controlled reaction between NO and superoxide anion. Indeed, although not a free radical in nature, peroxynitrite is much more reactive than its parent molecules NO and O2⋅-.

Kinetic studies indicated that peroxynitrite oxidized target molecules through two distinct mechanisms. First, peroxynitrite and its protonated form peroxynitrous acid (ONOOH) exerted direct oxidative modifications through one- or two-electron oxidation processes. Only a few chemical groups directly reacted with peroxynitrite, which favoured selective reactions with key moieties in proteins, such as thiols [137] and iron/sulphur centres [138]. The second mechanism involved peroxynitrite indirectly mediating oxidation by decomposing into highly reactive radicals. Indeed, peroxynitrite decomposition produces the highly reactive OH radicals, as well as nitrogen dioxide, which is a strong oxidant with significant cytotoxic potential [139, 140]. Nitrogen dioxide is also formed when peroxynitrite reacts with carbon dioxide. Such a reaction also leads to the formation of the radical anion carbonate (CO3⋅-):

Carbonate radical is more selective than hydroxyl radical but can initiate many of the damaging reactions commonly attributed to hydroxyl radical in the biological literature and is perhaps equally significant as a biological oxidant [141]. An important aspect of peroxynitrite-mediated toxicity is its capability of promoting protein tyrosine nitration through nitrogen dioxide and anion carbonate considered as a central aspect of peroxynitrite-mediated cytotoxicity [142].

10.1. Antioxidant System

Interestingly, the observations regarding free radicals were accompanied by the discovery that biological systems were equipped with an integrated antioxidant defence system capable of counteracting the damaging effects of ROS and RNS.

Catalase had been first noticed in 1818 by Louis Jacques Thénard, who discovered H2O2 and suggested that its breakdown was caused by an unknown substance [143], to which, in 1900, Oscar Loew gave the name catalase and found it in many plants and animals [144].

In 1957, Mills discovered an enzyme (GPX) using the reducing properties of glutathione for the protection of human erythrocytes against degradation of haemoglobin by hydrogen peroxide [145].

Previously, a heat-labile system capable of reducing GSSG was discovered in the liver by Hopkins and Elliott [146], and the next year, Mann [147] found that the hepatic GSSG reduction was linked to glucose oxidation by what was later identified as NADPH production in the pentose phosphate pathway. The enzyme directly involved in the reduction of GSSG, glutathione reductase (GR), was subsequently demonstrated in the rat liver by Rall and Lehninger [148]. Thus, it was realized that GPX and GR are the most important enzymes in maintaining cell redox homeostasis, since their combined action is the major determinant of reduced glutathione (GSH) content of tissues because GR serves to regenerate the active glutathione from its oxidized form produced in the GPX reaction.

Thioredoxin (Trx) was discovered in 1964 and characterized as a hydrogen donor for the enzymatic reduction of ribonucleotides in Escherichia coli [149]. The reduction reaction of thioredoxin required NADPH and was catalysed by a specific enzyme, which, in an accompanying work, was called thioredoxin reductase (TrxR) [150].

Subsequent investigation showed that the Trx/TrxR system is the major ubiquitous disulphide reductase responsible for maintaining proteins in their reduced state [151].

Until quite recently, CAT and GPX were thought to be the major peroxide-reducing enzymes protecting cells. The shift began in 1994 when protein sequence comparisons led to the recognition of a third abundant and widespread group of peroxidases [152]. The name peroxidoxins initially proposed for this group was quickly morphed to become the currently used peroxiredoxins (Prxs) [153]. These enzymes were quite distinct from catalases and GPXs especially in that they had no special cofactor but simply used cysteine residues for catalysis. Moreover, while for many Prxs the physiological reductant appears to be thioredoxin [152, 153], for some there exists a specific peroxiredoxin reductase (PrxR) that contains a thioredoxin-like domain [154]. As Prxs can also show high catalytic reactivity with peroxynitrite, they may also be important for defence against reactive nitrogen species [155].

11. Oxidative Stress

It is worth noting that in healthy organisms, the production of free radicals is low, and the antioxidant defence systems quickly remove ROS and the RNS before they cause structural and functional damage to the cell. The balance is not perfect so that some ROS and RNS-mediated damage occurs continuously, and damaged molecules must be repaired or replaced. This is demonstrated by the finding of ongoing oxidative damage in vivo in animals, including humans. For example, low levels of oxidative base damage products are present in DNA isolated from all aerobic cells. Low levels of carbonyls and certain products resulting from the attack of ROS upon proteins are detected in healthy animal tissues and body fluids. Age pigments accumulate in tissues, and specific end products of lipid peroxidation are present in body fluids [156]. These observations indicated that ROS-removing systems keep cellular levels of ROS in tissues rather than removing them completely. Moreover, it was understood that, in addition to exposure to high oxygen pressure and ionizing radiation, there were several different pathophysiological conditions in which the imbalance between the speed of production of free radicals and the capacity of the cellular defence systems becomes wider.

In 1985, Sies introduced the term “oxidative stress” to indicate this imbalance between prooxidants and antioxidants in favour of the former [157]. Severe oxidative stress produces DNA damage, rises in intracellular free Ca2+ and iron, damage to proteins (including membrane ion transporters), and lipid peroxidation.

Among the conditions that lead to the establishment of oxidative stress, there are, to name just a few, carbon tetrachloride toxicity; ischemia-reperfusion injury; hypermetabolic states, such as hyperthyroidism; and physical activity.

11.1. Carbon Tetrachloride Toxicity

It was long known that inhalation of vapours of carbon tetrachloride (CCl4), a chlorinated hydrocarbon used as a solvent for oils and fats, as a refrigerant and as a dry-cleaning agent could depress central nervous system activity and cause degeneration of the liver and kidneys [158]. However, there was a paucity of information concerning mechanisms of its action. Only in 1961, it was proposed that the hepatotoxic effects of CCl4 were due to the free radicals formed by homolytic scission of the carbon halogen bond [159]. In 1975, the existence of free radicals during CC14 metabolism was proven by an electron spin resonance study [160]. Subsequent investigation showed that reductive dehalogenation of CCl4 was catalysed by cytochrome P450, the terminal oxidase of the hepatic mixed-function oxidase system [161]. Moreover, it was found that low partial pressure of oxygen in tissue resulted in the predominant formation of CC13 and CHC12 radicals, whereas high partial pressure of oxygen shifts CC14 metabolism toward the formation of the CC13OO radical with consequent lipid peroxidation [162].

11.2. Ischemia-Reperfusion Injury

It is long known that, although restoration of blood flow is the sole method for salvaging ischemic tissues, the extent of injury often increases when the blood supply is restored. One example of reperfusion injury is the phenomenon of stunning that was described by Heyndrickx and colleagues in the dog heart in 1975 [163]. They showed that a myocardium reversibly injured by ischemia does not contract as efficiently as the control myocardium after reperfusion. The finding of the paradoxical enhancement of the injury response following reperfusion (or reoxygenation) of ischemic (or hypoxic) tissue led to the proposal that the sudden reintroduction of molecular oxygen to energy (and oxygen)-starved tissue results in a unique type of injury response that is not manifested during the period of hypoxic stress [164, 165]. Since its inception, the concept of reperfusion injury steadily gained attention likely for the implication of this mechanism of tissue injury in a growing list of organs. In the early 1980s, ROS were proposed as potential mediators of reperfusion injury because of the detection of chemical products generated by the reaction of ROS [166]. The idea that ROS could account for reperfusion injury was quickly embraced, mainly because it was consistent with the observation that interventions that enhanced ROS scavenging and/or detoxification protected against reperfusion injury following intestinal [102], myocardial [167, 168], and skeletal muscle [169] ischemia.

The oxidative stress elicited in tissues/cells following ischemia-reperfusion was linked to a variety of different sources of ROS, including xanthine oxidase, NADPH oxidase, and mitochondria. The hypothesis that xanthine oxidase is a major source of ROS was initially proposed by Shlafer et al. [167], which predicted that the accumulated hypoxanthine, arising from ATP metabolism, would react with the readmitted oxygen to produce a burst of superoxide, because of the conversion of the xanthine dehydrogenase to xanthine oxidase [170].

NADPH oxidase is another source that accounts for an important part of the ROS formed during ischemia-reperfusion.

Studies implicating neutrophils in reperfusion injury provided some of the earliest evidence suggesting the involvement of NOX as a source of ROS in postischemic tissue [171, 172]. However, there are several lines of evidence that support a role for nonphagocytic NOX as a source of ROS following I/R [173].

Mitochondria have been implicated as a major source of I/R-induced ROS production in a variety of organs. The proposal that the respiratory chain is a major source of ROS during reperfusion of the ischemic myocardium [174] was supported by the observation that a generation of oxygen radicals was induced in vitro upon reoxygenation of mitochondria isolated from hearts that had been subjected to ischemia [175]. Further support was obtained demonstrating by electron paramagnetic resonance that resumption of mitochondrial oxidative phosphorylation upon postischemic reflow can be a source of oxygen radicals in intact rabbit hearts [176]. It was proposed that, upon the respiration resumption, ROS generation is promoted by O2 interaction with ubisemiquinone, which accumulates in mitochondria during ischemia because of respiratory chain inhibition [177]. The observation that the increase in ischemia duration was directly related to a gradual increase in lipid peroxidation and decline in mitochondrial respiration and inversely related to functional recovery of the tissue [178] supported the idea that heart performance is strongly conditioned by mitochondrial functionality. Further support was provided by the observation that the antioxidant protection of mitochondrial function was associated with decreased impairment of cardiac function following ischemia-reperfusion [179].

11.3. Hyperthyroidism

It is long known that thyroid hormones are key regulators of growth, development, and metabolism. It is also well known that elevated circulating levels of thyroid hormones are associated with modifications in the whole organism and several body districts. The most studied modification found in hyperthyroid animals is the increase in their basal metabolic rate (BMR) due to an increase in the rate of O2 consumption in target tissues. The idea is well established that, like other long-term effects, thyroid calorigenesis is achieved by thyroid hormone influence on transcription of T3-responsive genes, which are mediated through nuclear thyroid hormone receptors (TRs) [180].

In the 80s, it was found that the hypermetabolic state in hyperthyroidism is associated with increases in lipid peroxidation in the rat liver [181], heart, and skeletal muscle [182]. Subsequent work demonstrated that products of lipid, protein, and DNA oxidation were found in several target tissues (see Di Meo and Venditti [183]for a review). More recent works showed stimulation of mitochondrial H2O2 generation following T3 treatment in the rat liver, heart, and skeletal muscle [184186].

It is worth noting that the long-term effects of thyroid hormone on mitochondrial respiration are obtained by increasing the content of electron carriers, such as cytochromes [187, 188] and ubiquinone [189, 190], and their percent reduction [188, 191]. There is also indirect evidence that even mitochondrial concentration of oxidizable electron carriers increases in hyperthyroid tissues [184, 185]. Thus, it is conceivable that the increase in mitochondrial ROS generation, underlying cellular oxidative damage, is a side effect of the thyroid hormone-induced biochemical changes by which animal tissues increase their metabolic capacity.

Moreover, significant evidence that tissue oxidative stress underlies some dysfunctions produced by hyperthyroidism has been obtained exploring the application of antioxidants, in particular, vitamin E, as therapeutic agents in thyroid-related disorders (see Venditti et al. [192]for a review).

11.4. Physical Activity

As regards the physical activity, we all had the experience that any form of exercise, if carried out vigorously enough, can become painful. But only one form of exercise, eccentric exercise, if unaccustomed to it, leaves us stiff and sore the next day. This is because acute exercise could produce significant damage, including structural and functional alterations in skeletal muscle as well as in other tissues. According to some reports, mitochondrial swelling is provoked in rat gastrocnemius muscle by running [193], and extensive mitochondrial swelling is provoked in the myocardium of both running and swimming rats [194]. Thus, an increase in the total area occupied by mitochondria and sarcoplasmic reticulum is found in middle gluteal muscle from treadmill-exercised horses [195].

Moreover, the extent of tissue damage mainly depends on the intensity and duration of exercise [184]. Serum elevation of creatine kinase and lactate dehydrogenase, universally accepted as a marker of tissue damage, is found in runners following an 80 km race [196].

Skeletal muscle injury also depends on the way how the muscle is used, because the contraction-induced injury is much more severe following eccentric rather than concentric or isometric contraction [197].

Although several metabolic factors have been proposed as mechanisms of primary damage during acute exercise, in the late 1970s, it was proposed that ROS can be implicated in the damage that develops in the tissues owing to long-lasting aerobic exercise [198], even though, until now, direct evidence of ROS production during physical activity increase is lacking. The first demonstration that an increase of free radicals verified in both muscle and liver of rat subjected to an exhaustive running was obtained by Davies et al. [199] using electron spin resonance. After which, with the same method, it was reported that exhaustive endurance exercise also increases the signal related to free radical generation in the rat heart [200] and in human serum [201]. Final confirmation that free radical production is enhanced by high muscular activity was obtained in experiments performed stimulating electrically skeletal muscles [202].

Muscle contraction also affects NO production as first demonstrated by the increase in NO release from muscles exposed to prior electrical stimulation [203] and NO concentrations in expired air during physical activity [204].

The changes in the content of the markers of lipid, protein, and DNA and in the redox state after acute exercise supply indirect information on the enhanced ROS production during acute exercise.

Ever since Dillard and his colleagues showed that in a subject exercised on a bicycle ergometer there is an increase in the exhaled air content of pentane, an index of lipid peroxidation [198], the information on the formation of oxidative damage markers after exercise in the tissues of various animals, among which humans, has increased [205, 206].

An important practical consequence of the demonstration that free radicals are involved in tissue damage caused by exhaustive exercise is that it is possible to minimize the effect of such radicals by the administration of antioxidants such as beta carotenes, vitamin C, vitamin E, glutathione, or N-acetylcysteine.

Since Brady et al. reported in 1979 that a 4-week vitamin E-reinforced diet (50 IU/kg diet) inhibited increases in rat liver TBARS levels immediately after exhaustive swimming exercise [207], the inhibitory effect of antioxidant intake on exercise-induced oxidative damage has been studied extensively. Most research has demonstrated that antioxidant administration has beneficial effects against the damaging effects of intense physical exercise (see Kawamura and Muraoka [208] for a review).

Apart from the protective role against damage caused by free radicals during exhaustive exercise, antioxidants might have a positive effect on performance and the prevention of fatigue. In 1994, Reid et al. used NAC, a precursor of GSH, to investigate the effects of free radicals on muscle fatigue and found that intravenous infusion of NAC inhibited tibialis anterior muscle fatigue induced by low-frequency electrical stimulation [209]. This study was the first human study to prove that free radicals can induce muscle fatigue and that supplementary intake of antioxidants can reverse it.

Based on these studies, nutritional interventions and antioxidant integration began to be used frequently in athletic populations to reduce oxidative damage, ameliorate the performance, and accelerate the recovery of muscle function.

12. Free Radicals and Diseases

Owing to increased understanding of the damaging effects of ROS, the concept of ROS as agents of cellular damage in biological organisms became widely accepted in theories of aging. Moreover, a growing number of diseases/disorders were gradually linked either directly or indirectly with ROS. That is, while some of these disorders are primarily due to free radicals, others may be only secondarily involved. In this latter group, tissue injured by various processes, such as trauma, toxic substances, and infectious processes, may undergo free radical damage more rapidly than healthy tissues. Tissue destruction and degeneration can result in increased oxidant damage, by such processes as metal ion release, phagocyte activation, and disruption of mitochondrial electron transport chains (so that more electrons “escape” to oxygen to form O2⋅-). It follows that almost any disease is likely to be accompanied by increased formation of reactive oxygen species.

The protective effects of iron chelation in several disorders [210], superoxide dismutase and catalase in ischemia-reperfusion [170], and the protection by vitamins, such as vitamin C [211, 212], and antioxidants, such as probucol [213], under a variety of experimental conditions clearly indicated a key role for free radicals in many disorders. The list of diseases in which the ROS formation was implicated was already long in 1987 (it contained over 50 diseases) [214], and it was destined to grow in the following years.

In Table 3, several human diseases/disorders are reported for which a role for oxidative stress has been suggested. Among these disorders, the aging process has been included. More than 300 theories have been proposed to explain the aging process [215], but none has yet been generally accepted by gerontologists. However, the initial proposal by Harman that free radicals are causally related to the basic aging process [70] has received increasing acceptance as a possible explanation of the chemical reactions at the basis of aging [216].

Adult respiratory distress syndromeGout
Allergic encephalomyelitisHaemachromatosis
Alzheimer’s diseaseHearing loss
Amyotrophic lateral sclerosisHypertension
AsbestosisInsulin resistance
AutismKeshan disease
Autoimmune vasculitisLypofuscinosis
Bloom syndromeMalaria
Bronchopulmonary dysplasiaMultiple sclerosis
BurnsMuscular dystrophy
CancerMyasthenia gravis
Chronic autoimmune gastritisParkinson disease
Chronic granulomatous diseasePsoriasis
Contact dermatitisRetinal degeneration
DepressionRetrolental fibroplasias
DermamyositisRheumatoid arthritis
Diabetes mellitusSickle cell anemia
EmphysemaSystemic lupus erythematosus
GlomerulonephritisUlcerative colitis

The identification of free radical reactions as promoters of the aging process implies that interventions aimed at limiting or inhibiting them should be able to reduce the rate of formation of aging changes with a consequent reduction of the aging rate and disease pathogenesis. However, even though dietary antioxidants appear to be important in delaying/preventing certain human diseases, especially cardiovascular disease and some types of cancer [217], available evidence does not allow to recommend antioxidant supplementation as a useful means to prevent age-related pathophysiological modifications and clinical conditions. Furthermore, several concerns are present not only about their efficacy but also on their safety.

13. Useful Effects of ROS

Although free radicals were considered harmful to the living organism for their damaging effects, it was long known that these effects could be exploited for the benefit of the organism.

14. Radiation Therapy

As previously mentioned, during early practical work and scientific investigation, experimenters noticed that prolonged exposure to X-rays created inflammation and, more rarely, tissue damage on the skin. The biological effect attracted the interest of several physicians, among which Emil Grubbe, who, only a month or two after Röentgen’s announcement also before understanding the physical properties and biological effects of X-rays, was the first physician known to use them for cancer treatment [218]. Interestingly, at that time, Grubbe was a student at the Hahnemann Medical College of Chicago. Because radiation was determined to be the cause of tumours, one of the professors at the homeopathic college suggested its therapeutic use in cancers. Thus, this incident has been considered by the proponents of homeopathic medicine as a further example from history in which an insight from a homeopathic perspective has provided an important breakthrough in medical treatment [219].

Radiation therapy uses particles or waves moving at a high frequency to target the DNA of cancer cells in the body and change the way they can replicate. Malignant tumours are characterized by unlimited cellular proliferation intimately connected with nucleic acid synthesis. If the DNA required for mitosis and replication is damaged, the cells are unable to replicate as usual and the growth of a cancerous tumour is inhibited. Of course, the mechanisms of the harmful effects of therapeutic exposure to ionizing radiation on tumour cells are the same as the effects of nontherapeutic exposure to radiation on normal cells. Therefore, radiation-induced ionizations can act directly on the cellular molecules and cause damage and can act indirectly producing free radicals which are derived from the ionization or excitation of the water component. Thus, hydroxyl radical generation is, paradoxically, the major mechanism by which malignant cells are killed during radiotherapy.

15. Phagocytosis

Another demonstration that free radicals could perform useful functions derived from the discovery that phagocytes (neutrophils, macrophages, and monocytes) release free radicals to destroy invading pathogenic microbes as part of the body’s defence mechanism against disease.

In normal phagocytosis, polymorphonuclear leukocytes and macrophages consume large quantities of oxygen when engulfing their prey. This “extra respiration of phagocytosis” had already been described by the first half of the 20th century [220]. However, the unusual nature of the process was only revealed in 1959 when it was discovered that it was not inhibited by classical mitochondrial poisons such as cyanide and azide [221] indicating that it was not simply a reflection of the enhanced energy requirements of phagocytosis. In 1964, Rossi and Zatti [94] correctly proposed that an NADPH oxidase was responsible for the respiratory burst, which was soon discovered to be a requirement for the efficient killing of bacteria by neutrophils [222]. This observation was rapidly reinforced by the recognition that a syndrome identified by Berendes et al. in 1957 [223] “fatal granulomatosis of childhood” (now referred to as chronic granulomatous disease) (CGD), which was characterized by a severe predisposition to pyogenic infection, was associated with the complete absence of this oxidase activity from the patient phagocytes [224].

In 1973, soon after its discovery, superoxide dismutase was used to show that the product generated by activated neutrophils was superoxide [95]:

Moreover, the next year, it was demonstrated that this process was lacking in CGD [225].

Thus, the importance of ROS production by the immune system was clearly exemplified by multiple and persistent infections arising in patients with CGD in which the defective membrane-bound NADPH oxidase system made them unable to produce the superoxide anion radical (O2⋅-) and therefore to kill bacteria.

This important development provided a direct link between free radical chemistry and biology. At the time, most free radical chemistry was conducted by radiation biologists in test tubes, and its application to biology was purely theoretical. This new discovery was thought to prove that the production of free radical reactions in a biological process was toxic enough to kill organic structures as tough as bacterial and fungal spores. Soon, these observations were extrapolated to implicate free radical reactions in a host of pathological processes involving neutrophil infiltration and tissue damage

Subsequently, several additional highly reactive oxygen-derived metabolites, including hydroxyl radical, singlet oxygen (1O2), and hypochlorous acid (HClO), were identified or predicted to exist as a result of activation of phagocytic cells [226].

The observation that SOD, CAT, and OH scavengers, such as benzoate and mannitol, inhibited the phagocytic killing suggested that both O2⋅- and H2O2 were required for the phagocytic bactericidal event and that OH generated by the interaction of O2⋅- and H2O2 in the Haber-Weiss reaction was the toxic agent for microorganisms [227].

On the other hand, another possible explanation for the requirement for both O2⋅- and H2O2 in the phagocytic activity might involve 1O2, which could be formed by a reaction between O2⋅- and OH:

The role of 1O2 in the killing of phagocytized bacteria had been suggested by the finding that Sarcina lutea containing carotenoid, a scavenger of 1O2, were protected against phagocytic bactericidal activity compared to a colourless mutant [228].

However, other reactive metabolites can be formed as a result of the metabolism of H2O2 by cellular enzymatic systems. The cytotoxicity of hydrogen peroxide itself is considerably enhanced in the presence of myeloperoxidase (MPO), which is simultaneously released from the azurophil granules into the phagocytic vacuoles. The enzyme-hydrogen peroxide complex that is formed can oxidize various halides to produce, for example, HClO, which has a potent bactericidal action [229]:

Singlet oxygen can, in turn, be formed by the interaction of H2O2 with hypochlorite [230]:

About a decade later, it was discovered that, in addition to NOX2-dependent production of oxygen radicals, murine macrophages have the capacity to produce nitrogen-based radicals that can contribute to microbial killing through an L-arginine-dependent biochemical pathway [231]. Such a study is proved to be more difficult to extrapolate to humans. Indeed, some studies showed low but detectable NO output [232, 233] that can be further increased by activating agents such as the chemotactic peptide N-formyl-L-methionyl-L-leucyl-L-phenylalanine [232]. Conversely, other studies failed to show NOS activity or the production of the NO metabolite nitrite and nitrate by human neutrophils, even after activation with proinflammatory cytokines [234, 235]. However, it is now indisputable that human macrophages produce NO and that NOS2, which is not expressed in macrophages at “rest,” is significantly enhanced in response to appropriate inflammatory stimuli [236]. The activity of this enzyme is required for the formation of nitrotyrosine around phagocytosed bacteria, most likely through the intermediate production of peroxynitrite [236].

16. Free Radicals as Signalling Molecules

According to several researchers, a new era of free radicals in biological systems began in the 1970s when Mittal and Murad provided evidence that hydroxyl radical induced the activation of guanylate cyclase and the genesis of the “second messenger” cyclic guanosine monophosphate (cGMP) [237]. However, as early as 1974, it had been reported that exogenously added hydrogen peroxide could mimic the signalling activity of insulin [238] and oxidation of key fat cell sulfhydryl’s in response to insulin receptor interaction playing a role in mediating the glucose transport activation [239].

This revelation remained within small free radical research circles until, at the end of the 70s, Mukherjee and Lynn [240] described a NADPH oxidase in membranes isolated from fat cells, the activity of which was stimulated by preincubation of cells with insulin. This provided the basis for an attractive hypothesis for the mechanism of action of insulin, according to which the hormone, through the stimulated H2O2 production, would mediate membrane sulfhydryl oxidation and thus promote glucose transport. In fact, a few years later, insulin was shown to activate a plasma membrane enzyme system with the properties of a NADPH oxidase resulting in the downstream production of H2O2 [241], which plays a role in facilitating normal signal transduction by insulin.

Moreover, in the 1980s, publications reported that low concentrations of superoxide and hydrogen peroxide H2O2 could also stimulate cell proliferation in hamsters [242] and human [243] fibroblasts in culture. Since then, a large body of evidence has been accumulated that, at the cellular level, ROS, besides acting as a “second messenger” of the insulin and stimulating growth responses in a variety of mammalian cell types [244], also regulate a wide variety of physiological functions.

Indeed, ROS were found to play crucial roles in the activation of genes under the control of the transcription factor NF-κB [245], be mediators in the biosynthesis of prostaglandins [246], function in embryonic development [247], and act as signalling molecules within the individual cell and among cells during their lifespan [248].

Evidence has been also obtained that ROS are involved in normal muscle contraction. This idea dates back to the 90s when Reid and collaborators [249] reported that low levels of ROS that are present in skeletal muscle under basal conditions are a requirement for normal movement and that antioxidant-mediated depletion of ROS from unfatigued skeletal muscle results in the inhibition of their contraction [250].

Furthermore, ROS contribute to complex functions, including blood pressure regulation [251] and cognitive function [252]. It has been also shown that, although an increased ROS formation rate has been postulated to be the major determinant of lifespan [253], several longevity-promoting interventions increase the generation of ROS that activate cellular stress pathways to dampen tissue degeneration to promote healthy aging [254]. This has suggested that living systems have not only adapted to a coexistence with free radicals but also developed various mechanisms for the advantageous use of free radicals in various physiological functions.

An important development in the field of the ROS beneficial effects was the discovery that, in organisms from simple bacteria to complex mammals, ROS can induce redox-sensitive signal cascades leading to increased expression of antioxidant enzymes.

For example, it was found that, following mouse [255] and rat [256] irradiation, cells and tissues appeared to respond by increasing the expression of cellular antioxidant defences, and this increased antioxidant capacity has been hypothesized to be at least partially responsible for radiation-induced adaptive responses. The increase in the effectiveness of the antioxidant defence system provided by this genetic response enables cells to survive an oxidant exposure that would normally be lethal.

Several studies showed that bacteria have evolved sophisticated molecular mechanisms to monitor oxidant levels and to activate antioxidant defence genes. In particular, the enteric bacterium Escherichia coli provided an excellent model to study gene regulation in response to oxidative stress. In fact, the basic principles of the oxidative stress response are universally conserved from bacteria to eukaryotes, although the exact mechanisms by which they sense ROS vary depending on the type and severity of stress condition and organism.

Thus, E. coli can stimulate the production of enzymes that scavenge the superoxide radical or various peroxides, of DNA repair enzymes, and of other proteins that mitigate the toxic effects of oxidative mutagens [257259]. These protective inductions represent adaptive responses to oxidative stress because they are triggered by nontoxic levels of oxidizing agents or ionizing radiation and protect cells against a subsequent challenge with otherwise lethal levels of those oxidants.

The bacterial oxyR gene was identified in Salmonella typhimurium as a regulator of acquired resistance to oxidative stress, and it was found to be required for the expression of 9 of the many stress proteins, including catalase, alkyl hydroperoxide reductase, glutathione reductase, and MnSOD, synthesized in response to sublethal levels of hydrogen peroxide [260].

Subsequent researches defined a genetic locus, the soxR regulon [261, 262], which is part of the multigene response to superoxide generators and positively regulates 9 of the ~40 polypeptides distinct from those induced by H2O2 [263].

It was discovered that in mammal genes, transcription determining cell survival can be activated by ROS in two ways: either via transcription factors, which can interact directly with specific DNA motifs on promoters of target genes, or via activation of mitogen-activated protein kinase cascades, which in turn activate transcription factors that trigger target gene transcription [264].

Indeed, clear evidence was obtained that ROS cellular levels are strongly linked to the regulation of cellular antioxidant levels. One of the main examples of this effect is the control of the expression of several genes that codify for antioxidant and detoxifying enzymes by the nuclear factor erythroid 2-related factor 2 (Nrf2). Its action is mediated through the bond to the antioxidant response element (ARE) together with the small musculoaponeurotic fibrosarcoma (Maf) proteins, of the promoter region of the target genes [265]. The activity of Nrf2 depends on its subcellular localization that is, in turn, dependent, at least in part, by its bond with specific residues of cysteine of the protein Kelch ECH-associating protein 1 (Keap1) [266]. Furthermore, ROS can interact and activate several cellular processes among which the proliferation and survival through the interaction with signalling molecules such as mitogen-activated protein kinases (MAPKs), phosphoinositide 3-kinases (PI3K), phosphatase and tensing homolog (PTEN), and protein tyrosine phosphatases [267].

Similarly, the RNS also exert a dual role being harmful or beneficial to the living systems. Nitric oxide, which was initially discovered as a signalling molecule able to modulate in blood vessel diameter [121], was subsequently identified as a molecule able to induce cellular toxicity and damage metabolic enzymes and to generate, reacting with superoxide, the peroxynitrite [268], as well as a regulator of important physiological processes [269].

Nitric oxide is probably the smallest and most versatile bioactive molecule identified. Early studies concerning the role of NO in mammalian organisms showed that, besides inducing vasorelaxation, NO inhibited platelet aggregation [270]. However, it was soon evident that the effects and function of NO went beyond its ability to regulate vascular tone and cell adhesion.

For example, it was found that nitric oxide influences considerably the central and peripheral nervous systems. In fact, stimulation of cerebellar slices with excitatory amino acids led to the release of a labile mediator with pharmacologic properties like those of NO, including the ability to raise cGMP in cerebellar cells that did not themselves respond to excitatory amino acids and the ability to relax vascular smooth muscle [271]. Subsequent studies on the peripheral nervous system provided the best evidence for a transmitter role of NO. NOS inhibitors selectively blocked nonadrenergic noncholinergic- (NANC-) mediated relaxation of the gastrointestinal tract [272]. These data coupled with the selective localization of nNOS to the myenteric plexus indicated that NO functions as the NANC neurotransmitter [273].

Interestingly, the observation that lipid peroxidation can be inhibited by excess NO and yield a variety of nitroso- and nitro-fatty acid-derived products [274] also demonstrated that NO can also function as an antioxidant since it terminates free radical processes and stops radical chain propagation reactions.

17. Mechanisms of Redox Signalling

Even though the ROS and RNS were involved in both cellular damage and signal transduction was well established, several controversial questions remained open.

Differences in the concentrations of the ROS and RNS could, at least in part, be responsible for the dual role of such species as essential molecules for the regulation of cellular functions and as harmful by-products of metabolism. Indeed, at low concentrations, ROS played an important role as regulatory mediators in signalling processes, whereas, at moderate or high concentrations, they were harmful to cell organisms inactivating important cellular molecules. This was analogous to the effects of nitric oxide, which had both regulatory functions and cytotoxic effects depending on the enzymatic source and relative amount of NO generated [275]. Thus, NO worked as a signalling molecule mediating vasodilation when produced in low concentrations by the constitutive isoform of nitric oxide synthase (eNOS) in vascular endothelial cells [276]. Conversely, it worked as a source of highly toxic oxidants, such as peroxynitrite and nitrogen dioxide (NO2), utilized for microbicidal killing when produced in high concentrations by iNOS in macrophages [277].

Although these results suggested that the cellular levels of reactive species determine the shift from their beneficial to harmful effects, the concentrations to which this shift happens were and still remain generally unknown today.

Moreover, there was an apparent contrast between the specificity that is required for signalling and the general reactivity of cellular ROS that renders them indiscriminate and potentially lethal oxidants, so that it was unclear how any specificity in their opposite actions could be achieved. Specificity in signalling is achieved through the noncovalent binding of a ligand to its cognate receptor due to the complementarity of macromolecular shapes. By contrast, ROS operate in signalling through chemical reactions with specific atoms of target proteins that lead to covalent protein modifications. Therefore, ROS molecular recognition occurs at the atomic level and not at the macromolecular level, which necessarily expands the potential number of ROS-specific receptors. Thus, it was unclear how the specificity was achieved in ROS signalling.

The cell type, duration of oxidant production, reactive species produced, and localization of their source and their targets were suggested as contributing factors [216], but the information on this topic was still scarce and discordant.


17.1. ROS Source

Regarding the ROS source, mitochondria are considered the main source of ROS in the cell in both physiological and pathological conditions [278]. This is why mitochondria are considered to play the main role in many diseases and in the aging process [279]. In fact, the available data show that the evidence of mitochondria as the main source of ROS is lacking [280]. Conversely, they show that there is a strong interaction among the different sources of cellular ROS [281, 282], and this renders it more difficult to define the main source of reactive species in different physiological and pathological conditions.

17.2. Colocalization of Sources and Targets of ROS

Another primary layer of control for ROS signalling is the colocalization of sources and targets of ROS by the generation of the small-molecule oxidant in proximity to a given substrate. This form of regulation can directly influence the kinetics of a putative chemical signalling reaction by controlling the local concentrations of the participating molecular reactants. For example, NOX proteins that influence receptor tyrosine kinase signalling are often colocalized with their putative physiological targets, such as phosphatases and kinases, at the plasma membrane. This also prevents oxidation of pathological targets such as nucleotides that are confined to other parts of the cell [283, 284]. Indeed, recent data show that ROS generation is localized for signalling in various cell types [285]. Other examples of colocalization of ROS signalling sources and targets are ER localization of NOX4 and its target, the protein tyrosine phosphatase 1B (PTP1B) [286] and the localized generation of HOCl by myeloperoxidase in phagosomes for pathogen defence [287].

17.3. Species Involved in Signalling

Most of the ROS cannot diffuse far from the site of their production due to their high instability and reactivity and to the antioxidant cellular capacity. This is the case of the radical OH which possesses a half-life of about 10−9 s for its high reactivity, differently from H2O2 which has a half-life of about 1 ms [288]. This explains why H2O2 can diffuse far from its source, differently from OH which has a mean effective radius of action of about 30 A and reacts with or very near to the biomolecule that produced it. Thus, a hydroxyl radical formed in the mitochondria will be unlikely to have a direct effect on other parts of the cell, for example, DNA in the nucleus.

Moreover, OH has indiscriminate reactivity toward biological molecules, whereas other ROS, such as O2⋅- and H2O2, each has preferred biological targets. Despite this, hydroxyl radical has also been thought to be involved in signalling by Mittal and Murad [237], who suggested that stimulation of guanylate cyclase by SOD was due to the formation of H2O2 which, reacting with superoxide, produced OH radicals that activated guanylate cyclase. This idea was refuted by Friebe et al. [289] who found that stimulation of guanylate cyclase by SOD was not influenced by OH and proposed that it was due to elimination of superoxide, thereby preventing its reaction with NO. Thus, the idea is widely shared that OH radical cannot play any specific role in signalling.

This does not seem to apply also for the derivatives of the nitric oxide. It had been assumed that peroxynitrite has an impact on pathways, which, under physiological conditions, are regulated by tyrosine phosphorylation and dephosphorylation. Although peroxynitrite does not react directly with tyrosine, all secondary radicals arising from peroxynitrite promote protein tyrosine oxidation and nitration [290]. The tyrosine nitration blocks the respective signalling cascades so that the fact that NO2 irreversibly binds to proteins seemed to have a pathological impact on cellular function, rather than contributing to physiological intracellular signalling. This agreed with the idea that the biological impact of primary and secondary reactive species is different. Primary ROS and RNS are regulated by SOD, CAT, GPX, and NOS, respectively, and are predominantly associated with signalling having a specific physiological function for the regulation of intracellular signalling. Conversely, the secondary species are associated with oxidative stress. They should be evolutionarily developed for extracellular actions, predominantly as part of the innate immune system for killing bacteria. The intracellular release of such secondary species leads to deleterious consequences, as these are highly active, without a reliable control system for intracellular levels. It was, therefore, generally assumed that, in evolution, the primary species were developed for intracellular physiological signalling whereas the secondary species, which can cause damage to the cell, were developed for extracellular actions, such as the killing of bacteria. Nevertheless, publications are dealing with the signalling role of peroxynitrite [291].

17.4. H2O2 Signalling

Most of the papers on ROS-mediated intracellular signalling suggested either O2⋅- or H2O2 as the major signalling molecules.

It was known that superoxide can oxidize thiols to thiyl radicals, which can initiate a chain reaction, but the rate constants for this reaction are rather low, about 103 M−1 s−1 at pH 7.4 [292], which are insignificant in comparison to the rate constants (about 109 M−1 s−1) for the cytosolic and mitochondrial superoxide dismutases [293]. When O2⋅- is generated by the NADPH oxidase isoform, NOX2, on the outside of cells, such as endothelial ones, it can enter cells, resulting in signalling [294]. However, inside the cell, it is rapidly dismuted to H2O2 and O2 and targets that react with which have not been demonstrated to do so in vivo so that it is likely that superoxide acts as a precursor of H2O2.

H2O2 enzymatic production and degradation, which provide specificity for time and place, and its chemistry, which provides specificity for the oxidation of thiols, qualify the peroxide a suitable second messenger.

It has been proposed that H2O2 initiates cellular signalling through modifications of target protein molecules or changes of the intracellular redox state [295], even though the distinction between these mechanisms is not easy.

The main targets of H2O2 are thiol groups of cysteine residues, and the best-described modification of the protein molecules involves the oxidation of such residues. Oxidation of –SH groups results in the formation of several different products, including sulfenic acid derivatives (-SOH) [296], which can subsequently undergo further oxidation to sulfinic (-SO2H) and eventually sulfonic (-SO3H) acid. Furthermore, they can form disulphide bonds with nearby cysteines (-S-S-) [297] and be transformed into several adducts by reaction with NO (S-nitrosylation) or GSH (S-glutathiolation) [298]. Except for sulfonic acid and to a lesser degree sulfinic acid, the modifications are reversible by reducing systems such as thioredoxin and peroxiredoxins [299].

The sulfinic acid formation requires a second reaction with H2O2 which seems more likely to occur under severe oxidative stress than during physiological signalling. The same is true for the sulfonic that practically does not exist in biological conditions. It follows that the oxidation states of a cysteine residue relevant for signalling are likely only the sulfenic acid derivative and the disulphide.

The oxidation-linked modifications of thiol groups result in changes in the structure and function of the protein, which may modify the activity of an enzyme if the critical cysteine is located within its catalytic domain [300] or the ability of a transcription factor to bind DNA if it is located within its DNA-binding motif [301]. Several proteins, including transcription factors, molecular chaperones, and protein tyrosine phosphatases, are regulated via redox processes. The redox state of protein thiols represents a “molecular switch” able to reversibly activate/deactivate protein function. This process resembles the phosphorylative regulation in which the addition of a phosphate group by a protein kinase and its removal by a protein phosphatase reversibly change protein activity [302].

On the other hand, crosstalk and/or sequential partnership between the two signalling mechanisms occur in some cases of cell regulation. Evidence linking the cellular redox state to a phosphorylative process came from the study of the Trx/ASK1 system [303]. Apoptosis signal-regulating kinase-1 (ASK1) is a member of the family of mitogen-activated protein kinase kinase kinases (MAPKKK) that is involved in the activation of stress-activated protein kinases, such as p38 and JNK [304]. Thioredoxin, an antioxidant protein, was found to form a complex with ASK1. When thioredoxin was complexed to ASK1, the activity of ASK1 was inhibited [303]. The rise in ROS levels that occurred following tumour necrosis factor stimulation resulted in the dissociation of ASK1 from thioredoxin and the subsequent activation of ASK1 activity [303].

As for how the changes in the redox cellular state initiate cellular signalling should be noted that, in comparison with the extracellular environment, the cytosol is normally maintained under strong “reducing” conditions. In normal conditions, the maintenance of the cytosol redox state is due to the “redox-buffering” capacity of intracellular thiols, such as GSH and Trx, which oppose cellular oxidative stress by reducing H2O2. The activity of GSH reductase and Trx reductase maintains the high ratios of reduction to oxidized forms of GSH and Trx, respectively. Such substances can participate in cell signalling processes: GSH can regulate redox signalling by alterations both in the level of total GSH and in the ratio between its reduced and oxidized forms, while Trx can regulate the activity of some proteins by directly binding to them [295].

17.5. NO Signalling

The well-known effect of NO on smooth muscle cells is due to the capacity of nitric oxide to bind to the heme moiety of guanylyl cyclase to induce a conformational change which activates the enzymes and results in the formation of the second messenger cyclic guanosine monophosphate (cGMP) from guanosine 5-triphosphate (GTP). cGMP in turn, regulates protein kinases (cGK), phosphodiesterases (PDE), and ion-gated channels. Since the initial elucidation of the effects of the NO/cGMP system on blood pressure regulation, platelet aggregation, and neurotransmission [305], other examples of the alternative target for NO came to light. Some examples are the activation of another heme-containing enzyme, cyclooxygenase, which leads to an increase in prostaglandin formation [306], and the inhibition of cytochrome oxidase, which regulates mitochondrial respiration [307].

Many biological effects of NO are mediated through heme-independent pathways by which S-nitrosylation of protein-associated targets of NO includes cysteine and tyrosine residues, and it is apparent that S-nitrosylation of target proteins is another potentially important regulatory system accounting for some of NO physiologic actions.

It was found that eNOS and iNOS are susceptible to NO-induced thiol modifications [308]. S-nitrosylation of NOS enzymes regulates the NO production suggesting a feedback mechanism to control its activity [308]. NO also targets the mitochondrial proteins complex I and complex IV involved in respiration. Although the inhibition of complex IV remains reversible throughout the time of exposure, the inhibition of complex I, which seems to be due to S-nitrosylation of this enzyme, becomes progressively persistent as the concentration of reduced glutathione (GSH) in the cell decreases [309].

Like NO, peroxynitrite easily crosses biological membranes, and despite a relatively short half-life (~10 ms), it can interact with target molecules in adjacent cells within one or two cell diameters [269]. Peroxynitrite can indirectly trigger the nitration of tyrosine residues in proteins, forming 3-nitrotyrosine, via the generation of highly reactive radicals formed by its reaction with carbon dioxide [310].

Protein tyrosine nitration is a covalent modification resulting from the addition of a nitro (-NO2) group onto one of the two equivalent ortho carbons of the aromatic ring of tyrosine [310]. The nitration may produce three distinct effects on the affected proteins: loss of function, the gain of function, or no effect [311]. Widespread tyrosine nitration occurred in cells during in vitro exposure to peroxynitrite, affecting structural proteins, ion channels, metabolic enzymes, and proteins involved in apoptosis, to name only a few [311313]. The relevance of such observations in vivo remained, however, to be established, given that the yield of nitrotyrosine formation under conditions of elevated peroxynitrite generation in vivo (nitrooxidative stress) remained largely smaller than what can be achieved in vitro with direct peroxynitrite exposure.

However, in most reported studies, nitration of tyrosine has been associated with a significant loss of function of the nitrated protein. An important example of the loss of enzyme activity is that of mitochondrial MnSOD, the first protein to be found nitrated in vivo [314]. Nitration of a single tyrosine residue (Tyr-34) leads to complete enzyme inactivation, with the possible consequence of favouring peroxynitrite generation in this organelle, due to the impaired dismutation of O2 [315].

A major aspect of tyrosine nitration by peroxynitrite is the possibility of impairment of cellular processes depending on the generation of phosphotyrosine [269]. It is worth noting that the hypothesis that tyrosine nitration would essentially inhibit phosphotyrosine-dependent cell signalling has been largely reviewed following a series of investigations concluding that peroxynitrite rather promoted the process of tyrosine phosphorylation in a variety of cell types [291]. Proposed mechanisms involve an imbalance between tyrosine phosphorylation and dephosphorylation, related to the activation of tyrosine kinases or the inhibition of tyrosine phosphatases, respectively, by peroxynitrite. However, the scarcity of in vivo results that confirm in vitro data indicates that the relevance of peroxynitrite-dependent signalling in pathological states remains to be specified.

18. Stress Antioxidative

The aforementioned results indicate that metabolic pathways of aerobic organisms lead to the obligate production of reactive oxygen species (ROS) and reactive nitrogen species (RNS), which are not necessarily bad. Reactive species are actually needed as signal transduction elements in processes that are essential for life.

Just as reactive species are not necessarily bad, antioxidants are not necessarily good. It is well accepted that oxidative stress is produced when the equilibrium between reactive species and antioxidants is tilted in favour of the former. However, it is now well established that the equilibrium can be broken also if antioxidant levels exceed those of the reactive species, and Dündar and Aslan [316] proposed the term “antioxidative stress” for such disequilibrium.

First, antioxidants play the role of blocking free radical production and oxidative stress, but they are not able to distinguish among radicals which produce damage and those that play a physiological role. Moreover, these compounds not only function as antioxidants but also have prooxidant action. For example, vitamin C is a well-known antioxidant, and Linus Pauling reported a pronounced effect of vitamin C in decreasing the incidence and delaying the onset of malignant lesions in rats [317] and mice [318] exposed to ultraviolet light. However, by now, a vast number of nutritional intervention trials using vitamin C, as well as other antioxidants, have shown no efficacy in preventing gastrointestinal cancer and delaying death [319]. Rather, they seem, to slightly shorten the lives of those who take them.

On the other hand, there is evidence that ascorbic acid can also act as a prooxidant. Vitamin C does not affect itself, but the combination with iron causes intense oxidation of polyunsaturated fats.

The superoxide ion is not a particularly reactive radical, and its toxicity is linked to the fact that it can reduce the Fe3+ ion to Fe2+ ion restoring a species, H2O2, which can produce the radical OH. Ascorbic acid also converts Fe3+ to Fe2+ thus allowing another cycle of OH generation from the renewed ferrous ion [320]. Integration with ascorbic acid leads to a constant supply of reduced ascorbic acid, thus leading to a repetitive generation of OH radicals by iron [320, 321]. Haematologists who studied iron overload due to transfusion therapy of patients with thalassemia or sickle cell disease reported that vitamin C can mobilize iron from their body iron stores to overwhelm the iron-binding capacity of iron-binding proteins and the resultant free iron-producing death within minutes to hours from iron-induced cardiac failure [322, 323]. Thus, vitamin C supplements can cause rapid progression to death of the otherwise more slowly progressive congestive cardiomyopathy of haemochromatosis [324]. Three young athletes so died, and no one thought of assessing their iron status before letting them take vitamin C supplements [325].

Moreover, because at low doses ROS possess a crucial role in many physiological functions, the balance between oxidant production and antioxidant protection is believed to be critical in maintaining healthy biological systems. Therefore, antioxidants at high doses besides acting as prooxidants, could also disrupt the redox balance following their potential to interact with ROS present at physiological concentrations required for optimal cellular functioning, leading to cellular dysfunction [326].

Furthermore, antioxidant supplementation can inhibit the adaptive response to ROS. A paradigmatic example is provided just by exercise. Indeed, a single session of strenuous or prolonged exercise leads to the production of a high number of radicals and other reactive oxygen species (ROS), which cause tissue damage and dysfunction. Conversely, the single sessions of a training program produce low amounts of ROS which can induce adaptive responses beneficial for the organism [327].

Interestingly, regular exercise appears to decrease the incidence of a wide range of ROS-associated diseases, including heart disease, T2DM, rheumatic arthritis, Alzheimer’s and Parkinson’s diseases, and certain cancers [328, 329].

The main adaptations occur in the trained skeletal muscle which can differ with the type of exercise but seem to be nevertheless dependent on ROS production. Thus, aerobic physical activity induces skeletal muscle adaptive responses [328], which increase resistance to conditions leading to increased ROS production including prolonged or strenuous exercise [330332]. Conversely, heavy resistance exercise results in hypertrophy of the muscle cells with an increase in strength, without major changes in biochemical makeup.

An important concept developed over the past decade is that the responses to training are likely the result of the acute but cumulative effects of the responses to single exercise bouts [333]. Thus, each bout of exercise initiates acute and transient changes in gene transcription which are reinforced by repeated exercise stimuli, leading to altered, chronic expression of a variety of nuclear and mitochondrial DNA (mtDNA) gene products, which ultimately form the basis of skeletal muscle training adaptation and improvements in exercise capacity [334]. Training also slows down peroxidative processes [331, 335] and the appearance of other signs of free radical generation [331] induced by acute exercise in rat skeletal muscle. This effect is associated with increased antioxidant defences [331, 336] and decreased free radical activity [337, 338].

It was suggested that the ROS generated during the single exercise sessions act as signals regulating molecular events crucial for the adaptive responses to training. It was also proposed that antioxidant supplementation, decreasing ROS formation, prevents useful adaptations for muscular cells [339]. Such an idea was tested determining the effects of the antioxidant supplementation on exercise-induced adaptive responses. Investigations concerning the effects of higher intakes of vitamin C and/or E on exercise performance and redox homeostasis have supplied contrasting results [340]. However, antioxidant supplementation has been more consistently reported to prevent health-promoting effects of physical exercise in humans [341, 342].

19. Conclusions

Our excursion into the field of free radicals has led us to point out that the scientific community has had to revise its ideas around these substances in quite a short time. Initially seen as substances that cannot be isolated due to the limitations of the available methods, they were then considered as short-lived substances, but important for their involvement in the combustion and organic synthesis processes. Subsequently, they were considered biochemical intermediates naturally occurring in biological systems, but impossible to identify. Thanks to the technique of electron spin resonance it was shown that free radicals were much more widespread in biological systems than previously assumed. The next step was the recognition that these species were responsible for the toxicity of oxygen and the deleterious effect of ionizing radiation.

Then came the evidence that free radicals were by-products of normal cellular metabolism and that their harmful effects were counteracted by an antioxidant defence system.

When the balance between free radical production and the capacity of antioxidant systems to neutralize them was disturbed in favour of the former, oxidative stress arose. This led to oxidative modification of biological macromolecules with consequent cell structural and functional dysfunction leading to diseases and aging.

The most recent stage has been the recognition that radicals at low concentrations can perform important functions in biological systems and that antioxidants can prevent such actions.

If subsequent researches will confirm such results, they will lead to a definitive rethinking of the idea that there has been for a long time about radicals and antioxidants. Above all, the still widespread habit of considering such substances as good and bad, respectively, would fall. Conversely, the idea would be affirmed that the goodness and badness of these substances are relative and are dependent on a series of factors, among which their concentration is very important.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Supplementary Materials

The figure is a graphical abstract. (Supplementary Materials)


  1. J. I. Solov’ev, Evoljucija osnpvnyh teoretičeskih problem himii, Izdatel’stvo Nauka, Mosca, 1971.
  2. J. Liebig and F. Wöhler, “Untersuchungen über das Radikal der Benzoesäure,” Annalen der Pharmacie, vol. 3, pp. 249–282, 1832. View at: Google Scholar
  3. H. J. H. Fenton, “LXXIII.—Oxidation oxidation of tartaric acid in presence of iron,” Journal of the Chemical Society, Transactions, vol. 65, pp. 899–910, 1894. View at: Publisher Site | Google Scholar
  4. F. Haber and R. Wilstätter, “Unpaarigheit und radikalketten im reaktion-mechanismus organscher und enzymatischer vorgange,” Chemische Berichte, vol. 64, pp. 2844–2856, 1931. View at: Google Scholar
  5. M. Gomberg, “An instance of trivalent carbon: triphenylmethyl,” Journal of the American Chemical Society, vol. 22, no. 11, pp. 757–771, 1900. View at: Publisher Site | Google Scholar
  6. M. Gomberg and L. H. Cone, “Ueber Triphenylmethyl,” Berichte der Deutschen Chemischen Gesellschaft, vol. 37, no. 2, pp. 2033–2051, 1904. View at: Publisher Site | Google Scholar
  7. M. Gomberg and L. H. Cone, “Ueber Triphenylmethyl,” Berichte der Deutschen Chemischen Gesellschaft, vol. 39, no. 3, pp. 2957–2970, 1906. View at: Publisher Site | Google Scholar
  8. V. von Richter, Organic Chemistry, or Chemistry of Carbon Compounds, Keegan Paul, Trench, Trubner, London, 1915.
  9. C. W. Porter, The Carbon Compounds: A Textbook of Organic Chemistry, Ginn, New York, NY, 1926.
  10. N. Bohr, “On the constitution of atoms and molecules,” Philosophical Magazine, vol. 26, pp. 1–24, 1913. View at: Google Scholar
  11. R. W. Wood, “XLIX. Atomic hydrogen and the balmer series spectrum,” The London, Edinburgh, and Dublin Philosophical Magazine and Journal of Science, vol. 44, no. 261, pp. 538–546, 1922. View at: Publisher Site | Google Scholar
  12. K. F. Bonhoeffer, “The behavior of active hydrogen,” Zeitschrift für Physikalische Chemie, vol. 113, pp. 199–219, 1924. View at: Google Scholar
  13. F. Paneth and W. Hofeditz, “Über die darstellung von freiem methyl,” European Journal of Inorganic Chemistry, vol. 32, pp. 1335–1347, 1929. View at: Google Scholar
  14. M. S. Kharasch and F. R. Mayo, “The peroxide effect in the addition of reagents to unsaturated compounds. I. The addition of hydrogen bromide to allyl bromide,” Journal of the American Chemical Society, vol. 55, no. 6, pp. 2468–2496, 1933. View at: Publisher Site | Google Scholar
  15. W. Markownikoff, “I. Ueber die Abhängigkeit der verschiedenen Vertretbarkeit des Radicalwasserstoffs in den isomeren Buttersäuren,” Annalen der Chemie und Pharmacie, vol. 153, no. 2, pp. 228–259, 1870. View at: Publisher Site | Google Scholar
  16. M. S. Kharasch and A. T. Read, “Sulfonation reactions with sulfuryl chloride,” Journal of the American Chemical Society, vol. 61, no. 11, pp. 3089–3092, 1939. View at: Publisher Site | Google Scholar
  17. M. S. Kharasch and H. C. Brown, “Chlorinations with sulfuryl chloride I. The peroxide-catalyzed chlorination of hydrocarbons,” Journal of the American Chemical Society, vol. 61, no. 8, pp. 2142–2150, 1939. View at: Publisher Site | Google Scholar
  18. M. S. Kharasch and H. C. Brown, “The photochemical reactions of oxalyl chloride and phosgene with cyclohexane,” Journal of the American Chemical Society, vol. 62, no. 2, pp. 454–454, 1940. View at: Publisher Site | Google Scholar
  19. N. N. Semenov, Chemical kinetics and chain reactions, Clarendon Press, Oxford, England, 1935.
  20. H. W. Thompson and C. N. Hinshelwood, “The mechanism of the homogeneous of hydrogen and oxygen,” Proceedings of the Royal Society B: Biological Sciences, vol. 12, pp. 610–621, 1928. View at: Google Scholar
  21. C. Moureau and C. Dufraisse, “Catalysis and auto-oxidation. Anti-oxygenic and pro-oxygenic activity,” Chemical Reviews, vol. 3, no. 2, pp. 113–162, 1926. View at: Publisher Site | Google Scholar
  22. G. Wolf, “The discovery of the antioxidant function of vitamin E: the contribution of Henry A. Mattill,” Journal of Nutrition, vol. 135, no. 3, pp. 363–366, 2005. View at: Publisher Site | Google Scholar
  23. M. J. Cummings and H. A. Mattill, “The auto-oxidation of fats with reference to their destructive effect on vitamin E,” Journal of Nutrition, vol. 3, no. 4, pp. 421–432, 1931. View at: Publisher Site | Google Scholar
  24. A. Szent-Györgyi, “Observations on the function of peroxidase systems and the chemistry of the adrenal cortex,” Biochemical Journal, vol. 22, no. 6, pp. 1387–1409, 1928. View at: Publisher Site | Google Scholar
  25. J. L. Svirbely and A. Szent-Györgyi, “The chemical nature of vitamin C,” Biochemical Journal, vol. 26, no. 3, pp. 865–870, 1932. View at: Publisher Site | Google Scholar
  26. L. Armentano, A. Bentsáth, T. Béres, S. Rusznyák, and A. Szent-Györgyi, “Über den Einfluß von Substanzen der Flavongruppe auf die Permeabilität der Kapillaren. Vitamin P1,” DMW - Deutsche Medizinische Wochenschrift, vol. 62, no. 33, pp. 1325–1328, 1936. View at: Publisher Site | Google Scholar
  27. F. Haber and J. Weiss, “The catalytic decomposition of hydrogen peroxide by iron salts,” Proceedings of the Royal Society of London. Series A: Mathematical and Physical Sciences, vol. 147, pp. 332–351, 1934. View at: Google Scholar
  28. K. Barbusiński, “Fenton reaction-controversy concerning the chemistry,” Ecological Chemistry and Engineering S, vol. 16, no. 3, pp. 347–358, 2009. View at: Google Scholar
  29. L. Michaelis, “The formation of semiquinones as intermediary reduction products from pyocyanine and other dyestuffs,” Journal of Biological Chemistry, vol. 92, pp. 211–232, 1931. View at: Google Scholar
  30. L. Michaelis, “Semiquinones, the intermediate steps of reversible organic oxidation-reduction,” Chemical Reviews, vol. 16, no. 2, pp. 243–286, 1935. View at: Publisher Site | Google Scholar
  31. H. Beinert, “Spectral characteristics of flavins at the semiquinoid oxidation level,” Journal of the American Chemical Society, vol. 78, pp. 5323–5328, 1935. View at: Google Scholar
  32. W. C. Röentgen, “On a new kind of rays,” Nature, vol. 53, pp. 274–276, 1896. View at: Google Scholar
  33. H. Becquerel, “Sur diverses propriétiés des rayons uraniques,” Comptes rendus hebdomadaires des séances de l'Académie des sciences, vol. 123, pp. 855–858, 1896. View at: Google Scholar
  34. P. Curie and M. Curie, “Sur une substance nouvelle radio-active contenue dans la pechblende,” Comptes rendus hebdomadaires des séances de l'Académie des sciences, vol. 127, pp. 175–178, 1898. View at: Google Scholar
  35. K. Sansare, V. Khanna, and F. Karjodkar, “Early victims of X-rays: a tribute and current perception,” Dento Maxillo Facial Radiology, vol. 40, no. 2, pp. 123–125, 2011. View at: Publisher Site | Google Scholar
  36. C. M. Scott, “Some quantitative aspects of the biological action of X- and γ-rays,” Some Quantitative Aspects of the Biological Action or X and y Rays, vol. 223, no. 223, p. 99, 1937. View at: Google Scholar
  37. W. M. Dale, “The effect of X rays on enzymes,” Biochemical Journal, vol. 34, no. 10-11, pp. 1367–1373, 1940. View at: Publisher Site | Google Scholar
  38. E. S. G. Barron, S. Dickman, J. A. Muntz, and T. P. Singer, “Studies on the mechanism of action of ionizing radiations,” The Journal of General Physiology, vol. 32, no. 4, pp. 537–552, 1949. View at: Publisher Site | Google Scholar
  39. J. Weiss, “Radiochemistry of aqueous solutions,” Nature, vol. 153, no. 3894, pp. 748–750, 1944. View at: Publisher Site | Google Scholar
  40. O. Risse, “Die physikalischen Grundlagen der chemischen Wirkungen des Lichts und der Röntgenstrahlen,” Ergebnisse der Physiologie, vol. 30, no. 1, pp. 242–293, 1930. View at: Publisher Site | Google Scholar
  41. H. Fricke, “The chemical-physical foundation for the biological effects of X-rays,” Cold Spring Harbor Symposia on Quantitative Biology, vol. 2, pp. 241–248, 1934. View at: Publisher Site | Google Scholar
  42. H. M. Patt, E. B. Tyree, R. L. Straube, and D. E. Smith, “Cysteine protection against X irradiation,” Science, vol. 110, no. 2852, pp. 213-214, 1949. View at: Publisher Site | Google Scholar
  43. H. Goldie, G. J. Tarleton Jr., and P. F. Hanh, “Effect of pretreatment with cysteine on survival of mice exposed to external and internal irradiation,” Experimental Biology and Medicine, vol. 77, no. 4, pp. 790–794, 1951. View at: Publisher Site | Google Scholar
  44. G. Schwartz, “Uber Desensibilisierung gegen Rontgen- und Radium-strahlen,” Munchener Medizinische Wochenschrift, vol. 24, pp. 1-2, 1909. View at: Google Scholar
  45. J. Jolly, “Action des rayons X sur les cellules. Modifications de la radiosensibilité par ligature des connexionsvasculaires,” Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales (Paris), vol. 91, pp. 351–354, 1924. View at: Google Scholar
  46. J. C. Mottram, “On the skin reactions to radium exposure and their avoidance in therapy; an experimental investigation,” British Journal of Radiology, vol. 29, pp. 174–180, 1924. View at: Google Scholar
  47. I. Churchill-Davidson, “Oxygen effect on radiosensitivity,” Cancer, vol. 13, no. S6, pp. 122–132, 1960. View at: Publisher Site | Google Scholar
  48. P. Howard-Flanders and T. Alper, “The sensitivity of microorganisms to irradiation under controlled gas conditions,” Radiation Research, vol. 7, no. 5, pp. 518–540, 1957. View at: Publisher Site | Google Scholar
  49. D. Ewing, “The oxygen fixation hypothesis: a reevaluation,” American Journal of Clinical Oncology, vol. 21, no. 4, pp. 355–361, 1998. View at: Publisher Site | Google Scholar
  50. F. Hutchinson, “The molecular basis for radiation effects on cells,” Cancer Research, vol. 26, pp. 2045–2052, 1996. View at: Google Scholar
  51. J. Du and J. M. Gebicki, “Proteins are major initial cell targets of hydroxyl free radicals,” The International Journal of Biochemistry & Cell Biology, vol. 36, no. 11, pp. 2334–2343, 2004. View at: Publisher Site | Google Scholar
  52. M. J. Daly, E. K. Gaidamakova, V. Y. Matrosova et al., “Protein oxidation implicated as the primary determinant of bacterial radioresistance,” PLoS Biology, vol. 5, no. 4, 2007. View at: Publisher Site | Google Scholar
  53. T. F. Slater, Free Radical Mechanisms in Tissue Injury, Pion Ltd., London, 1972.
  54. M. Comporti, C. Saccocci, and M. U. Dianzani, “Effect of CCl-4 in vitro and in vivo on lipid peroxidation of rat liver homogenates and subcellular fractions,” Enzymologia, vol. 29, no. 3, pp. 185–204, 1965. View at: Google Scholar
  55. R. O. Recknagel and A. K. Ghoshal, “Lipoperoxidation as a vector in carbon tetrachloride hepatotoxicity,” Laboratory Investigation, vol. 15, pp. 132–146, 1966. View at: Google Scholar
  56. T. F. Slater, “Necrogenic action of carbon tetrachloride in the rat: a speculative mechanism based on activation,” Nature, vol. 209, no. 5018, pp. 36–40, 1966. View at: Publisher Site | Google Scholar
  57. K. J. A. Davies, “Oxidative stress: the paradox of aerobic life,” Biochemical Society Symposia, vol. 61, pp. 1–31, 1995. View at: Publisher Site | Google Scholar
  58. J. Priestley, “An account of further discoveries in air,” Philosophical Transactions, vol. 65, pp. 384–394, 1775. View at: Google Scholar
  59. C. W. Scheele, Chemische Abhandlung von der Luft und dem Feuer: nebsteinem Vorbericht, Uppsala und Leipzig, Verlegt von Magn, Swederus, 1777.
  60. M. M. V. Regnault and J. Reiset, Recherches chimiques sur la respiration des animaux des diverses classes, Ann Chim Phys Bachelier, Imprimeur-Libraire, Paris, 1849.
  61. P. Bert, “La pression barométrique: recherches de physiologie expérimentale,” Tech. Rep., Masson, Paris, 1878. View at: Google Scholar
  62. J. L. Smith, “The pathological effects due to increase of oxygen tension in the air breathed,” The Journal of Physiology, vol. 24, no. 1, pp. 19–35, 1899. View at: Publisher Site | Google Scholar
  63. T. L. Terry, “Fibroblastic overgrowth of persistent tunica vasculosa lentis in infants born prematurely: II. Report of cases-clinical aspects,” Transactions of the American Ophthalmological Society, vol. 40, pp. 262–284, 1942. View at: Google Scholar
  64. K. Campbell, “Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach,” Medical Journal of Australia, vol. 2, no. 2, pp. 48–50, 1951. View at: Publisher Site | Google Scholar
  65. J. W. Bean, “Effects of oxygen at increased pressure,” Physiological Reviews, vol. 25, no. 1, pp. 1–147, 1945. View at: Publisher Site | Google Scholar
  66. N. Haugaard, “Cellular mechanisms of oxygen toxicity,” Physiological Reviews, vol. 48, no. 2, pp. 311–373, 1968. View at: Publisher Site | Google Scholar
  67. H. Taube, “Mechanisms of oxidation with oxygen,” The Journal of General Physiology, vol. 49, no. 1, pp. 29–50, 1965. View at: Publisher Site | Google Scholar
  68. R. Gerschman, D. L. Gilbert, S. W. Nye, P. Dwyer, and W. O. Fenn, “Oxygen poisoning and x-irradiation: a mechanism in common,” Science, vol. 119, no. 3097, pp. 623–626, 1954. View at: Publisher Site | Google Scholar
  69. B. Commoner, J. Townsend, and G. E. Pake, “Free radicals in biological materials,” Nature, vol. 174, no. 4432, pp. 689–691, 1954. View at: Publisher Site | Google Scholar
  70. D. Harman, “Aging: a theory based on free radical and radiation chemistry,” The Journals of Gerontology, vol. 11, no. 3, pp. 298–300, 1956. View at: Publisher Site | Google Scholar
  71. J. M. McCord and I. Fridovich, “Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein),” Journal of Biological Chemistry, vol. 244, no. 22, pp. 6049–6055, 1969. View at: Google Scholar
  72. J. M. McCord and I. Fridovich, “The reduction of cytochrome c by milk xanthine oxidase,” Journal of Biological Chemistry, vol. 243, no. 21, pp. 5753–5760, 1968. View at: Google Scholar
  73. T. Mann and D. Keilin, “Haemocuprein and hepatocuprein, copper-protein compounds of blood and liver in mammals,” Proceedings of the Royal Society of London, Series B: Biological Sciences, vol. 126, no. 844, pp. 303–315, 1938. View at: Google Scholar
  74. J. M. McCord, B. B. Keele, and I. Fridovich, “An enzyme-based theory of obligate anaerobiosis: the physiological function of superoxide dismutase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 68, no. 5, pp. 1024–1027, 1971. View at: Publisher Site | Google Scholar
  75. L. W. Oberley, A. L. Lindgren, S. A. Baker, and R. H. Stevens, “Superoxide ion as the cause of the oxygen effect,” Radiation Research, vol. 68, no. 2, pp. 320–328, 1976. View at: Publisher Site | Google Scholar
  76. D. T. Sawyer and J. S. Valentine, “How super is superoxide?” Accounts of Chemical Research, vol. 14, no. 12, pp. 393–400, 1981. View at: Publisher Site | Google Scholar
  77. J. A. Fee, “Is superoxide important in oxygen poisoning?” Trends in Biochemical Sciences, vol. 7, no. 3, pp. 84–86, 1982. View at: Publisher Site | Google Scholar
  78. N. Pastor, H. Weinstein, E. Jamison, and M. Brenowitz, “A detailed interpretation of OH radical footprints in a TBP-DNA complex reveals the role of dynamics in the mechanism of sequence-specific binding,” Journal of Molecular Biology, vol. 304, no. 1, pp. 55–68, 2000. View at: Publisher Site | Google Scholar
  79. S. J. Weiss, G. W. King, and A. F. LoBuglio, “Evidence for hydroxyl radical generation by human monocytes,” Journal of Clinical Investigation, vol. 60, no. 2, pp. 370–373, 1977. View at: Publisher Site | Google Scholar
  80. S. R. Thomas, D. Mohr, and R. Stocker, “Nitric oxide inhibits indoleamine 2, 3-dioxygenase activity in interferon-gamma primed mononuclear phagocytes,” Journal of Biological Chemistry, vol. 269, no. 20, pp. 14457–14464, 1994. View at: Google Scholar
  81. P. K. Jensen, “Antimycin-insensitive oxidation of succinate and reduced nicotinamide-adenine dinucleotide in electron-transport particles I. pH dependency and hydrogen peroxide formation,” Biochimica et Biophysica Acta (BBA) - Enzymology and Biological Oxidation, vol. 122, no. 2, pp. 157–166, 1966. View at: Publisher Site | Google Scholar
  82. G. Loschen, L. Flohe, and B. Chance, “Respiratory chain linked H2O2production in pigeon heart mitochondria,” FEBS Letters, vol. 18, no. 2, pp. 261–264, 1971. View at: Publisher Site | Google Scholar
  83. R. A. Weisiger and I. Fridovich, “Superoxide dismutase. Organelle specificity,” Journal of Biological Chemistry, vol. 248, no. 10, pp. 3582–3592, 1973. View at: Google Scholar
  84. G. Loschen, A. Azzi, C. Richter, and L. Flohé, “Superoxide radicals as precursors of mitochondrial hydrogen peroxide,” FEBS Letters, vol. 42, no. 1, pp. 68–72, 1974. View at: Publisher Site | Google Scholar
  85. A. Boveris and B. Chance, “The mitochondrial generation of hydrogen peroxide: general properties and effect of hyperbaric oxygen,” Biochemical Journal, vol. 134, no. 3, pp. 707–716, 1973. View at: Publisher Site | Google Scholar
  86. J. H. Gillette, B. B. Brodie, and B. N. La Du, “The oxidation of drugs by liver microsomes: on the role of TPNH and oxygen,” Journal of Pharmacology and Experimental Therapeutics, vol. 119, no. 4, pp. 532–540, 1957. View at: Google Scholar
  87. A. G. Hildebrandt and I. Roots, “Reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent formation and breakdown of hydrogen peroxide during mixed function oxidation reactions in liver microsomes,” Archives of Biochemistry and Biophysics, vol. 171, no. 2, pp. 385–397, 1975. View at: Publisher Site | Google Scholar
  88. J. Werringloer, Microsomes and Drug Oxidations, V. Ullrich, J. Roots, A. G. Hildebrandt, R. W. Estabrook, and A. H. Conney, Eds., Pergamon Press, Oxford, 1977.
  89. S. D. Aust, D. L. Roerig, and T. C. Pederson, “Evidence for superoxide generation by NADPH-cytochrome C reductase of rat liver microsomes,” Biochemical and Biophysical Research Communications, vol. 47, no. 5, pp. 1133–1137, 1972. View at: Publisher Site | Google Scholar
  90. G. M. Bartoli, T. Galeotti, G. Palombini, G. Parici, and A. Azzi, “Different contribution of rat liver microsomal pigments in the formation of superoxide anions and hydrogen peroxide during development,” Archives of Biochemistry and Biophysics, vol. 181, pp. 276–281, 1977. View at: Google Scholar
  91. C. de Duve, “Functions of microbodies (peroxisomes),” Journal of Cell Biology, vol. 27, 1965. View at: Google Scholar
  92. A. Boveris, N. Oshino, and B. Chance, “The cellular production of hydrogen peroxide,” Biochemical Journal, vol. 128, no. 3, pp. 617–630, 1972. View at: Publisher Site | Google Scholar
  93. G. Y. N. Iyer, D. M. F. Islam, and J. H. Quastel, “Biochemical aspects of phagocytosis,” Nature, vol. 192, no. 4802, pp. 535–541, 1961. View at: Publisher Site | Google Scholar
  94. F. Rossi and M. Zatti, “Biochemical aspects of phagocytosis in polymorphonuclear leucocytes. NADH and NADPH oxidation by the granules of resting and phagocytizing cells,” Experientia, vol. 20, no. 1, pp. 21–23, 1964. View at: Publisher Site | Google Scholar
  95. B. M. Babior, R. S. Kipnes, and J. T. Curnutte, “Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent,” Journal of Clinical Investigation, vol. 52, no. 3, pp. 741–744, 1973. View at: Publisher Site | Google Scholar
  96. A. W. Segal and O. T. Jones, “Novel cytochrome b system in phagocytic vacuoles of human granulocytes,” Nature, vol. 276, no. 5687, pp. 515–517, 1978. View at: Publisher Site | Google Scholar
  97. B. Royer-Pokora, L. M. Kunkel, A. P. Monaco et al., “Cloning the gene for an inherited human disorder– chronic granulomatous disease–on the basis of its chromosomal location,” Nature, vol. 322, pp. 32–38, 1978. View at: Google Scholar
  98. K. Bedard and K. H. Krause, “The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology,” Physiological Reviews, vol. 87, no. 1, pp. 245–313, 2007. View at: Publisher Site | Google Scholar
  99. B. A. Freeman and J. D. Crapo, “Biology of disease: free radicals and tissue injury,” Laboratory Investigation, vol. 47, no. 5, pp. 412–426, 1982. View at: Google Scholar
  100. F. Schardinger, “Ueber das Verhalten der Kuhmilch gegen Methylenblau und seine Verwendung zur Unterscheidung von ungekochter und gekochter Milch,” Zeitschrift für Untersuchung der Nahrungs- und Genussmittel, vol. 5, no. 22, pp. 1113–1121, 1902. View at: Publisher Site | Google Scholar
  101. E. Della Corte and F. Stirpe, “The regulation of rat-liver xanthine oxidase: activation by proteolytic enzymes,” FEBS Letters, vol. 2, no. 2, pp. 83-84, 1968. View at: Publisher Site | Google Scholar
  102. D. N. Granger, G. Rutili, and J. M. McCord, “Superoxide radicals in feline intestinal ischemia,” Gastroenterology, vol. 81, no. 1, pp. 22–29, 1981. View at: Publisher Site | Google Scholar
  103. R. Korthuis and D. N. Granger, “Ischemia-reperfusion injury: role of oxygen-derived free radicals,” in Physiology of Oxygen Radicals, A. E. Taylor, S. Matalon, and P. A. Ward, Eds., pp. 217–249, Am Physiol Sot (Clin Physiol Ser), Bethesda, MD, 1986. View at: Google Scholar
  104. J. Priestley, Experiment and Observation on Different Kinds of Air, vol. 1, Johnson J, St. Paul Church Yard, London, 1774.
  105. D. F. Ashman, R. Lipton, M. M. Melicow, and T. D. Price, “Isolation of adenosine 3,5-monophosphate and guanosine 3,5-monophosphate from rat urine,” Biochemical and Biophysical Research Communications, vol. 11, no. 4, pp. 330–334, 1963. View at: Publisher Site | Google Scholar
  106. T. D. Price, D. F. Ashman, and M. M. Melicow, “Organophosphates of urine, including adenosine 3,5-monophosphate and guanosine 3,5-monophosphate,” Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, vol. 138, no. 3, pp. 452–465, 1967. View at: Publisher Site | Google Scholar
  107. K. G. Nair, “Purification and properties of 3’,5’-cyclic nucleotide phosphodiesterase from dog heart,” Biochemistry, vol. 5, no. 1, pp. 150–157, 1966. View at: Publisher Site | Google Scholar
  108. J. G. Hardman and E. W. Sutherland, “Guanyl cyclase, an enzyme catalyzing the formation of guanosine 3’,5’-monophosphate from guanosine trihosphate,” Journal of Biological Chemistry, vol. 244, no. 23, pp. 6363–6370, 1969. View at: Google Scholar
  109. K.-D. Schultz, K. Schultz, and G. Schultz, “Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deferens,” Nature, vol. 265, no. 5596, pp. 750-751, 1977. View at: Publisher Site | Google Scholar
  110. S. Katsuki, W. Arnold, C. Mittal, and F. Murad, “Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine,” Journal of Cyclic Nucleotide Research, vol. 3, pp. 23–25, 1977. View at: Google Scholar
  111. F. Murad, C. K. Mittal, W. P. Arnold, S. Katsuki, and H. Kimura, “Guanylate cyclase: activation by azide, nitro compounds, nitric oxide and hydroxyl radical and inhibition by hemoglobin and myoglobin,” Advances in Cyclic Nucleotide Research, vol. 9, pp. 145–158, 1978. View at: Google Scholar
  112. W. R. Kukovetz, S. Holzmann, and G. Pöch, “Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle,” Naunyn-Schmiedeberg’s Archives of Pharmacology, vol. 310, no. 2, pp. 129–138, 1979. View at: Publisher Site | Google Scholar
  113. R. F. Furchgott and J. V. Zawadzki, “The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine,” Nature, vol. 288, no. 5789, pp. 373–376, 1980. View at: Publisher Site | Google Scholar
  114. P. D. Cherry, R. F. Furchgott, J. V. Zawadzki, and D. Jothianandan, “Role of endothelial cells in relaxation of isolated arteries by bradykinin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 79, no. 6, pp. 2106–2110, 1982. View at: Publisher Site | Google Scholar
  115. R. M. Rapoport and F. Murad, “Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP,” Circulation Research, vol. 52, no. 3, pp. 352–357, 1983. View at: Publisher Site | Google Scholar
  116. R. M. Rapoport, M. B. Draznin, and F. Murad, “Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation,” Nature, vol. 306, no. 5939, pp. 174–176, 1983. View at: Publisher Site | Google Scholar
  117. R. F. Furchgott, “Role of endothelium in responses of vascular smooth muscle,” Circulation Research, vol. 53, no. 5, pp. 557–573, 1983. View at: Publisher Site | Google Scholar
  118. T. M. Griffith, D. H. Edwards, M. J. Lewis, A. C. Newby, and A. H. Henderson, “The nature of endothelium-derived vascular relaxant factor,” Nature, vol. 308, no. 5960, pp. 645–647, 1984. View at: Publisher Site | Google Scholar
  119. R. F. Furchgott, “Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from bovine retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide,” in Mechanisms of Vasodilatation, P. M. Vanhoutte, Ed., vol. 4, pp. 401–414, Raven Press, New York, NY, 1988. View at: Google Scholar
  120. L. J. Ignarro, R. E. Byrns, and K. S. Wood, “Biochemical and pharmacological properties of EDRF and its similanty to nitric oxide radical,” in Mechanisms of Vasodilatation, P. M. Vanhoutte, Ed., vol. 4, pp. 427–435, Raven Press, New York, NY, 1988. View at: Google Scholar
  121. L. J. Ignarro, G. M. Buga, K. S. Wood, R. E. Byrns, and G. Chaudhuri, “Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 24, pp. 9265–9269, 1987. View at: Publisher Site | Google Scholar
  122. M. T. Khan and R. F. Furchgott, “Additional evidence that endothelium-derived relaxing factor is nitric oxide,” in Pharmacology, M. J. Rand and C. Raper, Eds., pp. 341–344, Elsevier, Amsterdam, 1987. View at: Google Scholar
  123. R. M. J. Palmer, A. G. Ferrige, and S. Moncada, “Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor,” Nature, vol. 27, pp. 524–526, 1987. View at: Google Scholar
  124. R. M. J. Palmer, D. S. Ashton, and S. Moncada, “Vascular endothelial cells synthesize nitric oxide from L-arginine,” Nature, vol. 333, no. 6174, pp. 664–666, 1988. View at: Publisher Site | Google Scholar
  125. D. S. Bredt and S. H. Snyder, “Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 2, pp. 682–685, 1990. View at: Publisher Site | Google Scholar
  126. U. Forstermann, J. S. Pollock, H. H. Schmidt, M. Heller, and F. Murad, “Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 5, pp. 1788–1792, 1991. View at: Publisher Site | Google Scholar
  127. D. J. Stuehr, H. J. Cho, N. S. Kwon, M. F. Weise, and C. F. Nathan, “Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 17, pp. 7773–7777, 1991. View at: Publisher Site | Google Scholar
  128. R. J. Gryglewski, R. M. J. Palmer, and S. Moncada, “Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor,” Nature, vol. 320, no. 6061, pp. 454–456, 1986. View at: Publisher Site | Google Scholar
  129. N. V. Blough and O. C. Zafiriou, “Reaction of superoxide with nitric oxide to form peroxonitrite in alkaline aqueous solution,” Inorganic Chemistry, vol. 24, no. 22, pp. 3502–3504, 1985. View at: Publisher Site | Google Scholar
  130. E. Halfpenny and P. L. Robinson, “169. The nitration and hydroxylation of aromatic compounds by pernitrous acid,” Journal of the Chemical Society (Resumed), pp. 939–946, 1952. View at: Publisher Site | Google Scholar
  131. A. Baeyer and V. Villiger, “Ueber die salpetrige Säure,” Berichte der Deutschen Chemischen Gesellschaft, vol. 34, no. 1, pp. 755–762, 1901. View at: Publisher Site | Google Scholar
  132. L. R. Mahoney, “Evidence for the formation of hydroxyl radicals in the isomerization of pernitrous acid to nitric acid in aqueous solution,” Journal of the American Chemical Society, vol. 92, no. 17, pp. 5262-5263, 1970. View at: Publisher Site | Google Scholar
  133. E. O. Feigl, “EDRF --a protective factor?” Nature, vol. 331, no. 6156, pp. 490-491, 1988. View at: Publisher Site | Google Scholar
  134. T. B. McCall, N. K. Boughton-Smith, R. M. J. Palmer, B. J. R. Whittle, and S. Moncada, “Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion,” Biochemical Journal, vol. 261, no. 1, pp. 293–296, 1989. View at: Publisher Site | Google Scholar
  135. J. S. Beckman, T. W. Beckman, J. Chen, P. A. Marshall, and B. A. Freeman, “Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 4, pp. 1620–1624, 1990. View at: Publisher Site | Google Scholar
  136. V. M. Darley-Usmar, N. Hogg, V. J. O’Leary, M. T. Wilson, and S. Moncada, “The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein,” Free Radical Research Communications, vol. 17, no. 1, pp. 9–20, 1992. View at: Publisher Site | Google Scholar
  137. R. Radi, J. S. Beckman, K. M. Bush, and B. A. Freeman, “Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide.,” Journal of Biological Chemistry, vol. 266, no. 7, pp. 4244–4250, 1991. View at: Google Scholar
  138. L. Castro, M. Rodriguez, and R. Radi, “Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide,” The Journal of Biological Chemistry, vol. 269, no. 47, pp. 29409–29415, 1994. View at: Google Scholar
  139. W. A. Pryor and J. W. Lightsey, “Mechanisms of nitrogen dioxide reactions: initiation of lipid peroxidation and the production of nitrous acid,” Science, vol. 214, no. 4519, pp. 435–437, 1981. View at: Publisher Site | Google Scholar
  140. J. M. Patel and E. R. Block, “Nitrogen dioxide-induced changes in cell membrane fluidity and function,” The American Review of Respiratory Disease, vol. 134, no. 6, pp. 1196–1202, 1986. View at: Publisher Site | Google Scholar
  141. A. M. Michelson and J. Maral, “Carbonate anions; effects on the oxidation of luminol, oxidative hemolysis, γ-irradiation and the reaction of activated oxygen species with enzymes containing various active centres,” Biochimie, vol. 65, no. 2, pp. 95–104, 1983. View at: Publisher Site | Google Scholar
  142. A. Dinicola, B. A. Freeman, M. Trujillo, and R. Radi, “Peroxynitrite reaction with carbon dioxide/bicarbonate: kinetics and influence on peroxynitrite-mediated oxidations,” Archives of Biochemistry and Biophysics, vol. 333, no. 1, pp. 49–58, 1996. View at: Publisher Site | Google Scholar
  143. L. J. Thénard, “Observations sur des nouvelles combinaisons entre loxigène et divers acides,” Annales de Chimie et de Physique, vol. 8, pp. 306–312, 1818. View at: Google Scholar
  144. O. Loew, “A new enzyme of general occurrence in organismis,” Science, vol. 11, no. 279, pp. 701-702, 1900. View at: Publisher Site | Google Scholar
  145. G. C. Mills, “Hemoglobin catabolism. I. Glutathione peroxidase, an erythrocyte enzyme which protects hemoglobin from oxidative breakdown,” The Journal of Biological Chemistry, vol. 229, no. 1, pp. 189–197, 1957. View at: Google Scholar
  146. F. G. Hopkins and K. A. C. Elliott, “The reduction of glutathione to cell respiration with special reference to hepatic tissue,” Proceedings of the Royal Society B: Biological Sciences, vol. 109, pp. 58–88, 1931. View at: Publisher Site | Google Scholar
  147. P. J. G. Mann, “The reduction of glutathione by a liver system,” The Biochemical Journal, vol. 26, no. 3, pp. 785–790, 1932. View at: Publisher Site | Google Scholar
  148. T. W. Rall and A. L. Lehninger, “Glutathione reductase of animal tissues,” The Journal of Biological Chemistry, vol. 194, no. 1, pp. 119–130, 1952. View at: Google Scholar
  149. T. C. Laurent, E. C. Moore, and P. Reichard, “Enzymatic synthesis of deoxyribonucleotides IV. Isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli B,” The Journal of Biological Chemistry, vol. 239, pp. 3436–3444, 1964. View at: Google Scholar
  150. E. C. Moore, P. Reichard, and L. Thelander, “Enzymatic synthesis of deoxyribonucleotides V. Purification and properties of thioredoxin reductase from Escherichia coli B,” Journal of Biological Chemistry, vol. 239, pp. 3445–3452, 1964. View at: Google Scholar
  151. A. Holmgren, “Enzymatic reduction-oxidation of protein disulfides by thioredoxin,” Methods in Enzymology, vol. 107, pp. 295–300, 1984. View at: Publisher Site | Google Scholar
  152. H. Z. Chae, S. J. Chung, and S. G. Rhee, “Thioredoxin-dependent peroxide reductase from yeast,” The Journal of Biological Chemistry, vol. 269, no. 44, pp. 27670–27678, 1994. View at: Google Scholar
  153. H. Z. Chae, H. J. Kim, S. W. Kang, and S. G. Rhee, “Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin,” Diabetes Research and Clinical Practice, vol. 45, no. 2-3, pp. 101–112, 1999. View at: Publisher Site | Google Scholar
  154. L. B. Poole, C. M. Reynolds, Z. A. Wood, P. A. Karplus, H. R. Ellis, and M. Li Calzi, “AhpF and other NADH:peroxiredoxin oxidoreductases, homologues of low Mr thioredoxin reductase,” European Journal of Biochemistry, vol. 267, no. 20, pp. 6126–6133, 2000. View at: Publisher Site | Google Scholar
  155. R. Bryk, P. Griffin, and C. Nathan, “Peroxynitrite reductase activity of bacterial peroxiredoxins,” Nature, vol. 407, no. 6801, pp. 211–215, 2000. View at: Publisher Site | Google Scholar
  156. B. Halliwell and J. M. C. Gutteridege, Free Radicals in Biology and Medicine, Oxford University Press, Oxford, UK, 1985.
  157. H. Sies, “Oxidative stress: introductory remarks,” in Oxidative Stress, H. Sies, Ed., pp. 1–7, Academic Press, San Diego, 1985. View at: Google Scholar
  158. C. Young, “Carbon tetrachloride poisoning,” Canadian Medical Association Journal, vol. 35, no. 4, pp. 419–421, 1936. View at: Google Scholar
  159. T. C. Butler, “Reduction of carbon tetrachloride in vivo and reduction of carbon tetrachloride in vitro by tissue homogenates,” The Journal of Pharmacology and Experimental Therapeutics, vol. 134, pp. 311–319, 1975. View at: Google Scholar
  160. A. Calligar and V. Vannini, “Electron spin resonance study of homolytic cleavage of carbon tetrachloride in rat liver: trichloromethyl free radicals,” Pharmacological Research Communications, vol. 7, no. 4, pp. 323–329, 1975. View at: Publisher Site | Google Scholar
  161. T. Nogushi, K. L. Fong, E. K. Lai et al., “Specificity of a phenobarbital-induced cytochrome P-450 for metabolism of carbon tetrachloride to the trichloromethyl radical,” Biochemical Pharmacology, vol. 31, no. 5, pp. 615–624, 1982. View at: Publisher Site | Google Scholar
  162. H. De Groot, A. Littauer, D. Hugo-Wissemann, P. Wissemann, and T. Noll, “Lipid peroxidation and cell viability in isolated hepatocytes in a redesigned oxystat system: evaluation of the hypothesis that lipid peroxidation, preferentially induced at low oxygen partial pressures, is decisive for CCl4 liver cell injury,” Archives of Biochemistry and Biophysics, vol. 264, no. 2, pp. 591–599, 1988. View at: Publisher Site | Google Scholar
  163. G. R. Heyndrickx, R. W. Millard, R. J. McRitchie, P. R. Maroko, and S. F. Vatner, “Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs,” The Journal of Clinical Investigation, vol. 56, no. 4, pp. 978–985, 1975. View at: Publisher Site | Google Scholar
  164. D. J. Hearse, S. M. Humphrey, and E. B. Chain, “Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release,” Journal of Molecular and Cellular Cardiology, vol. 5, no. 4, pp. 395–407, 1973. View at: Publisher Site | Google Scholar
  165. D. J. Hearse, “Reperfusion of the ischemic myocardium,” Journal of Molecular and Cellular Cardiology, vol. 9, no. 8, pp. 605–616, 1977. View at: Publisher Site | Google Scholar
  166. C. Guarnieri, F. Flamigni, and C. M. Caldarera, “Role of oxygen in the cellular damage induced by re-oxygenation of hypoxic heart,” Journal of Molecular and Cellular Cardiology, vol. 12, no. 8, pp. 797–808, 1980. View at: Publisher Site | Google Scholar
  167. M. Shlafer, P. F. Kane, and M. M. Kirsh, “Superoxide dismutase plus catalase enhances the efficacy of hypothermic cardioplegia to protect the globally ischemic, reperfused heart,” The Journal of Thoracic and Cardiovascular Surgery, vol. 83, no. 6, pp. 830–839, 1982. View at: Publisher Site | Google Scholar
  168. A. S. Manning, D. J. Coltart, and D. J. Hearse, “Ischemia and reperfusion-induced arrhythmias in the rat. Effects of xanthine oxidase inhibition with allopurinol,” Circulation Research, vol. 55, no. 4, pp. 545–548, 1984. View at: Publisher Site | Google Scholar
  169. R. J. Korthuis, D. N. Granger, M. I. Townsley, and A. E. Taylor, “The role of oxygen- derived free radicals in ischemia-induced increases in canine skeletal muscle vascular permeability,” Circulation Research, vol. 57, no. 4, pp. 599–609, 1985. View at: Publisher Site | Google Scholar
  170. J. M. McCord, “Oxygen-derived free radicals in postischemic tissue injury,” The New England Journal of Medicine, vol. 312, no. 3, pp. 159–163, 1985. View at: Publisher Site | Google Scholar
  171. J. L. Romson, B. G. Hook, S. L. Kunkel, G. D. Abrams, M. A. Schork, and B. R. Lucchesi, “Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog,” Circulation, vol. 67, no. 5, pp. 1016–1023, 1983. View at: Publisher Site | Google Scholar
  172. S. M. Smith, L. Holm-Rutili, M. A. Perry et al., “Role of neutrophils in hemorrhagic shock-induced gastric mucosal injury in the rat,” Gastroenterology, vol. 93, no. 3, pp. 466–471, 1987. View at: Publisher Site | Google Scholar
  173. C. E. Walder, S. P. Green, W. C. Darbonne et al., “Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase,” Stroke, vol. 28, no. 11, pp. 2252–2258, 1997. View at: Publisher Site | Google Scholar
  174. M. L. Hess and N. H. Manson, “Molecular oxygen: friend and foe: the role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injury,” Journal of Molecular and Cellular Cardiology, vol. 16, no. 11, pp. 969–985, 1984. View at: Publisher Site | Google Scholar
  175. H. Otani, H. Tanaka, T. Inoue et al., “In vitro study on contribution of oxidative metabolism of isolated rabbit heart mitochondria to myocardial reperfusion injury,” Circulation Research, vol. 55, no. 2, pp. 168–175, 1984. View at: Publisher Site | Google Scholar
  176. G. Ambrosio, J. L. Zweier, C. Duilio et al., “Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow,” The Journal of Biological Chemistry, vol. 268, pp. 18532–18541, 1993. View at: Google Scholar
  177. A. P. Halestrap, E. J. Griffiths, and C. P. Connern, “Mitochondrial calcium handling and oxidative stress,” Biochemical Society Transactions, vol. 21, no. 2, pp. 353–358, 1993. View at: Publisher Site | Google Scholar
  178. P. Venditti, P. Masullo, and S. Di Meo, “Effects of myocardial ischemia and reperfusion on mitochondrial function and susceptibility to oxidative stress,” Cellular and Molecular Life Sciences, vol. 58, no. 10, pp. 1528–1537, 2001. View at: Publisher Site | Google Scholar
  179. P. S. Brookes, S. B. Digerness, and D. A. Parks, “Mitochondrial function in response to cardiac ischemia-reperfusion after oral treatment with quercetin,” Free Radical Biology & Medicine, vol. 32, no. 11, pp. 1220–1228, 2002. View at: Publisher Site | Google Scholar
  180. J. H. Oppenheimer, “Thyroid hormone action at the cellular level,” Science, vol. 203, no. 4384, pp. 971–979, 1979. View at: Publisher Site | Google Scholar
  181. V. Fernández, X. Barrientos, K. Kipreos, A. Valenzuela, and L. A. Videla, “Superoxide radical generation, NADPH oxidase activity and cytochrome P-450 content of rat liver microsomal fractions in an experimental hyperthyroid state: relation to lipid peroxidation,” Endocrinology, vol. 117, no. 2, pp. 496–501, 1985. View at: Publisher Site | Google Scholar
  182. K. Asayama, K. Dobashi, H. Hayashibe, Y. Megata, and K. Kato, “Lipid peroxidation and free radical scavengers in thyroid dysfunction in the rat: a possible mechanism of injury to heart and skeletal muscle in hyperthyroidism,” Endocrinology, vol. 121, no. 6, pp. 2112–2118, 1987. View at: Publisher Site | Google Scholar
  183. P. Venditti and S. Di Meo, “Thyroid hormone-induced oxidative stress,” Cellular and Molecular Life Sciences, vol. 63, no. 4, pp. 414–434, 2006. View at: Publisher Site | Google Scholar
  184. P. Venditti, R. De Rosa, and S. Di Meo, “Effect of thyroid state on H2O2 production by rat liver mitochondria,” Molecular and Cellular Endocrinology, vol. 205, no. 1-2, pp. 185–192, 2003. View at: Publisher Site | Google Scholar
  185. P. Venditti, A. Puca, and S. Di Meo, “Effects of thyroid state on H2O2 production by rat heart mitochondria: sites of production with complex I and complex II-linked substrates,” Hormone and Metabolic Research, vol. 35, no. 1, pp. 55–61, 2003. View at: Publisher Site | Google Scholar
  186. P. Venditti, A. Puca, and S. Di Meo, “Effect of thyroid state on rate and sites of H2O2 production in rat skeletal muscle mitochondria,” Archives of Biochemistry and Biophysics, vol. 411, no. 1, pp. 121–128, 2003. View at: Publisher Site | Google Scholar
  187. K. Nishiki, M. Erecinska, D. F. Wilson, and S. Cooper, “Evaluation of oxidative phosphorylation in hearts from euthyroid, hypothyroid and hyperthyroid rats,” American Journal of Physiology-Cell Physiology, vol. 235, no. 5, pp. C212–C219, 1978. View at: Publisher Site | Google Scholar
  188. M. A. Horrum, R. B. Tobin, and E. Ecklund, “Thyroxine-induced changes in rat liver mitochondrial cytochromes,” Molecular and Cellular Endocrinology, vol. 41, no. 2-3, pp. 163–169, 1985. View at: Publisher Site | Google Scholar
  189. P. Venditti, R. De Rosa, and S. Di Meo, “Effect of thyroid state on susceptibility to oxidants and swelling of mitochondria from rat tissues,” Free Radical Biology & Medicine, vol. 35, no. 5, pp. 485–494, 2003. View at: Publisher Site | Google Scholar
  190. M. A. Horrum, R. B. Tobin, and R. E. Ecklund, “Thyroxine-induced changes in rat liver mitochondrial ubiquinone,” Biochemical and Biophysical Research Communications, vol. 138, no. 1, pp. 381–386, 1986. View at: Publisher Site | Google Scholar
  191. J. R. Bronk, “Thyroid hormone: effects on electron transport,” Science, vol. 153, no. 3736, pp. 638-639, 1966. View at: Publisher Site | Google Scholar
  192. P. Venditti, L. Di Stefano, and S. Di Meo, “Vitamin E management of oxidative damage-linked dysfunctions of hyperthyroid tissues,” Cellular and Molecular Life Sciences, vol. 70, no. 17, pp. 3125–3144, 2013. View at: Publisher Site | Google Scholar
  193. P. D. Gollnick and D. W. King, “Effect of exercise and training on mitochondria of rat skeletal muscle,” American Journal of Physiology-Legacy Content, vol. 216, no. 6, pp. 1502–1509, 1969. View at: Publisher Site | Google Scholar
  194. D. W. King and P. D. Gollnick, “Ultrastructure of rat heart and liver after exhaustive exercise,” The American Journal of Physiology, vol. 218, no. 4, pp. 1150–1155, 1970. View at: Publisher Site | Google Scholar
  195. L. J. McCutcheon, S. K. Byrd, and D. R. Hodgson, “Ultrastructural changes in skeletal muscle after fatiguing exercise,” Journal of Applied Physiology, vol. 72, no. 3, pp. 1111–1117, 1992. View at: Publisher Site | Google Scholar
  196. M. M. Kanter, G. R. Lesmes, L. A. Kaminsky, J. la Ham-Saeger, and N. D. Nequin, “Serum creatine kinase and lactate dehydrogenase changes following an eighty kilometer race,” European Journal of Applied Physiology, vol. 57, no. 1, pp. 60–63, 1988. View at: Publisher Site | Google Scholar
  197. K. K. McCully and J. A. Faulkner, “Injury to skeletal muscle fibers of mice following lengthening contractions,” Journal of Applied Physiology, vol. 59, no. 1, pp. 119–126, 1985. View at: Publisher Site | Google Scholar
  198. C. J. Dillard, R. E. Litov, W. M. Savin, E. E. Dumelin, and A. L. Tappel, “Effects of exercise, vitamin E, and ozone on pulmonary function and lipid peroxidation,” Journal of Applied Physiology, vol. 45, no. 6, pp. 927–932, 1978. View at: Publisher Site | Google Scholar
  199. K. J. A. Davies, A. T. Quintanilha, G. A. Brooks, and L. Packer, “Free radicals and tissue damage produced by exercise,” Biochemical and Biophysical Research Communications, vol. 107, no. 4, pp. 1198–1205, 1982. View at: Publisher Site | Google Scholar
  200. C. T. Kumar, V. K. Reddy, M. Prasad, K. Thyagaraju, and P. Reddanna, “Dietary supplementation of vitamin E protects heart tissue from exercise-induced oxidant stress,” Molecular and Cellular Biochemistry, vol. 111, no. 1-2, pp. 109–115, 1992. View at: Publisher Site | Google Scholar
  201. T. Ashton, C. C. Rowlands, E. Jones et al., “Electron spin resonance spectroscopic detection of oxygen-centred radicals in human serum following exhaustive exercise,” European Journal of Applied Physiology and Occupational Physiology, vol. 77, no. 6, pp. 498–502, 1998. View at: Publisher Site | Google Scholar
  202. M. J. Jackson, R. H. T. Edwards, and M. C. R. Symons, “Electron spin resonance studies of intact mammalian skeletal muscle,” Biochimica et Biophysica Acta-Molecular Cell Research, vol. 847, no. 2, pp. 185–190, 1985. View at: Publisher Site | Google Scholar
  203. T. W. Balon and J. L. Nadler, “Nitric oxide release is present from incubated skeletal muscle preparations,” Journal of Applied Physiology, vol. 77, no. 6, pp. 2519–2521, 1994. View at: Publisher Site | Google Scholar
  204. A. Matsumoto, Y. Hirata, S. I. Momomura et al., “Increased nitric oxide production during exercise,” The Lancet, vol. 343, no. 8901, pp. 849-850, 1994. View at: Publisher Site | Google Scholar
  205. K. Fisher-Wellman and R. J. Bloomer, “Acute exercise and oxidative stress: a 30 year history,” Dynamic Medicine, vol. 8, no. 1, 2009. View at: Publisher Site | Google Scholar
  206. S. K. Powers and M. J. Jackson, “Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production,” Physiological Reviews, vol. 88, no. 4, pp. 1243–1276, 2008. View at: Publisher Site | Google Scholar
  207. P. S. Brady, L. J. Brady, and D. E. Ullrey, “Selenium, vitamin E and the response to swimming stress in the rat,” The Journal of Nutrition, vol. 109, no. 6, pp. 1103–1109, 1979. View at: Publisher Site | Google Scholar
  208. T. Kawamura and I. Muraoka, “Exercise-induced oxidative stress and the effects of antioxidant intake from a physiological viewpoint,” Antioxidants, vol. 7, no. 9, p. 119, 2018. View at: Publisher Site | Google Scholar
  209. M. B. Reid, D. S. Stokić, S. M. Koch, F. A. Khawli, and A. A. Leis, “N-Acetylcysteine inhibits muscle fatigue in humans,” The Journal of Clinical Investigation, vol. 94, no. 6, pp. 2468–2474, 1994. View at: Publisher Site | Google Scholar
  210. B. Halliwell and J. M. C. Gutteridge, “The importance of free radicals and catalytic metal ions in human diseases,” Molecular Aspects of Medicine, vol. 8, no. 2, pp. 89–193, 1985. View at: Publisher Site | Google Scholar
  211. K. H. Beyer, “Protective action of vitamin C against experimental hepatic damage,” Archives of Internal Medicine, vol. 71, no. 3, pp. 315–324, 1943. View at: Publisher Site | Google Scholar
  212. B. Frei, “Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage,” The American Journal of Clinical Nutrition, vol. 54, no. 6, pp. 1113S–1118S, 1991. View at: Publisher Site | Google Scholar
  213. S. Parthasarathy, S. G. Young, J. L. Witztum, R. C. Pittman, and D. Steinberg, “Probucol inhibits oxidative modification of low density lipoprotein,” The Journal of Clinical Investigation, vol. 77, no. 2, pp. 641–644, 1986. View at: Publisher Site | Google Scholar
  214. B. Halliwell, “Oxidants and human disease: some new concepts1,” The FASEB Journal, vol. 1, no. 5, pp. 358–364, 1987. View at: Publisher Site | Google Scholar
  215. Z. A. Medvedev, “An attempt at a rational classification of theories of ageing,” Biological Reviews, vol. 65, no. 3, pp. 375–398, 1990. View at: Publisher Site | Google Scholar
  216. T. Finkel and N. J. Holbrook, “Oxidants, oxidative stress and the biology of ageing,” Nature, vol. 408, no. 6809, pp. 239–247, 2000. View at: Publisher Site | Google Scholar
  217. A. T. Diplock, “Antioxidant nutrients and disease prevention: an overview,” The American Journal of Clinical Nutrition, vol. 53, 1, Supplement, pp. 189S–193S, 1991. View at: Publisher Site | Google Scholar
  218. E. H. Grubbe, “Priority in the therapeutic use of X-rays,” Radiology, vol. 21, no. 2, pp. 156–162, 1933. View at: Publisher Site | Google Scholar
  219. D. Ullman, Omeopathic Revolution, North Atlantic Books, Berkeley, California, 2007.
  220. C. W. Baldridge and R. W. Gerard, “The extra respiration of phagocytosis,” The American Journal of Physiology, vol. 103, pp. 235-236, 1933. View at: Google Scholar
  221. A. J. Sbarra and M. L. Karnovsky, “The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes,” The Journal of Biological Chemistry, vol. 234, no. 6, pp. 1355–1362, 1959. View at: Google Scholar
  222. R. J. Selvaraj and A. J. Sbarra, “Relationship of glycolytic and oxidative metabolism to particle entry and destruction in phagocytosing cells,” Nature, vol. 211, no. 5055, pp. 1272–1276, 1966. View at: Publisher Site | Google Scholar
  223. H. Berendes, R. A. Bridges, and R. A. Good, “A fatal granulomatosus of childhood: the clinical study of a new syndrome,” Minnesota Medicine, vol. 40, no. 5, pp. 309–312, 1957. View at: Google Scholar
  224. B. Holmes, A. R. Page, and R. A. Good, “Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function,” The Journal of Clinical Investigation, vol. 46, no. 9, pp. 1422–1432, 1967. View at: Publisher Site | Google Scholar
  225. J. T. Curnutte, D. M. Whitten, and B. M. Babior, “Defective superoxide production by granulocytes from patients with chronic granulomatous disease,” The New England Journal of Medicine, vol. 290, no. 11, pp. 593–597, 1974. View at: Publisher Site | Google Scholar
  226. J. C. Fantone and P. A. Ward, “Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions,” The American Journal of Pathology, vol. 107, no. 3, pp. 395–418, 1982. View at: Google Scholar
  227. R. B. Johnston Jr., B. B. Keele Jr., H. P. Misra et al., “The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes,” Journal of Clinical Investigation, vol. 55, no. 6, pp. 1357–1372, 1975. View at: Publisher Site | Google Scholar
  228. N. I. Krinsky, “Singlet excited oxygen as a mediator of the antibacterial action of leukocytes,” Science, vol. 186, no. 4161, pp. 363–365, 1974. View at: Publisher Site | Google Scholar
  229. S. J. Klebanoff, “Myeloperoxidase-halide-hydrogen peroxide antibacterial system,” Journal of Bacteriology, vol. 95, no. 6, pp. 2131–2138, 1968. View at: Publisher Site | Google Scholar
  230. H. Rosen and S. J. Klebanoff, “Formation of singlet oxygen by the myeloperoxidase-mediated antimicrobial system,” The Journal of Biological Chemistry, vol. 252, no. 14, pp. 4803–4810, 1977. View at: Google Scholar
  231. J. B. Hibbs Jr., R. R. Taintor, and Z. Vavrin, “Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite,” Science, vol. 235, no. 4787, pp. 473–476, 1987. View at: Publisher Site | Google Scholar
  232. H. H. H. W. Schmidt, R. Seifert, and E. Böhme, “Formation and release of nitric oxide from human neutrophils and HL-60 cells induced by a chemotactic peptide, platelet activating factor and leukotriene B4,” FEBS Letters, vol. 244, no. 2, pp. 357–360, 1989. View at: Publisher Site | Google Scholar
  233. D. Salvemini, G. de Nucci, R. J. Gryglewski, and J. R. Vane, “Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 16, pp. 6328–6332, 1989. View at: Publisher Site | Google Scholar
  234. M. Schneemann, G. Schoedon, S. Hofer, N. Blau, L. Guerrero, and A. Schaffner, “Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes,” The Journal of Infectious Diseases, vol. 167, no. 6, pp. 1358–1363, 1993. View at: Publisher Site | Google Scholar
  235. M. L. Cameron, D. L. Granger, J. B. Weinberg, W. J. Kozumbo, and H. S. Koren, “Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate,” The American Review of Respiratory Disease, vol. 142, 6, Part 1, pp. 1313–1319, 1990. View at: Publisher Site | Google Scholar
  236. T. J. Evans, L. D. Buttery, A. Carpenter, D. R. Springall, J. M. Polak, and J. Cohen, “Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 18, pp. 9553–9558, 1996. View at: Publisher Site | Google Scholar
  237. C. K. Mittal and F. Murad, “Activation of guanylate cyclase by superoxide dismutase and hydroxyl radical: a physiological regulator of guanosine 3,5-monophosphate formation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 74, no. 10, pp. 4360–4364, 1977. View at: Publisher Site | Google Scholar
  238. M. P. Czech, J. C. Lawrence, and W. S. Lynn, “Evidence for electron transfer reactions involved in Cu2+-dependent thiol activation of fat cell glucose utilization,” The Journal of Biological Chemistry, vol. 249, pp. 1001–1006, 1974. View at: Google Scholar
  239. M. P. Czech, J. C. Lawrence Jr., and W. S. Lynn, “Evidence for the involvement of sulfhydryl oxidation in the regulation of fat cell hexose transport by insulin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 71, no. 10, pp. 4173–4177, 1974. View at: Publisher Site | Google Scholar
  240. S. P. Mukherjee and W. S. Lynn, “Reduced nicotinamide adenine dinucleotide phosphate oxidase in adipocyte plasma membrane and its activation by insulin: possible role in the hormones effects on adenylate cyclase and the hexose monophosphate shunt,” Archives of Biochemistry and Biophysics, vol. 184, no. 1, pp. 69–76, 1977. View at: Publisher Site | Google Scholar
  241. J. M. May and C. de Haen, “Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells,” The Journal of Biological Chemistry, vol. 254, no. 7, pp. 2214–2220, 1979. View at: Google Scholar
  242. R. H. Burdo and C. Rice-Evans, “Free radicals and the regulation of mammalian cell proliferation,” Free Radical Research Communications, vol. 6, no. 6, pp. 345–358, 1989. View at: Publisher Site | Google Scholar
  243. G. A. C. Murrell, J. O. F. R. A. N. C. I. S. Martin, and L. Bromley, “Oxygen free radicals stimulate fibroblast proliferation,” Biochemical Society Transactions, vol. 17, no. 3, pp. 484–484, 1989. View at: Publisher Site | Google Scholar
  244. R. H. Burdon, “Free radicals and cell proliferation,” in Free Radical Damage and Its Control, R. H. Burdon and C. Rice-Evans, Eds., pp. 155–188, Elsevier, Amsterdam, The Netherlands, 1994. View at: Google Scholar
  245. R. Schreck, P. Rieber, and P. A. Baeuerle, “Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1,” The EMBO Journal, vol. 10, no. 8, pp. 2247–2258, 1991. View at: Publisher Site | Google Scholar
  246. F. A. Kuehl Jr. and R. W. Egan, “Prostaglandins, arachidonic acid, and inflammation,” Science, vol. 210, no. 4473, pp. 978–984, 1980. View at: Publisher Site | Google Scholar
  247. O. D. Saugstad, “Update on oxygen radical disease in neonatology,” Current Opinion in Obstetrics & Gynecology, vol. 13, no. 2, pp. 147–153, 2001. View at: Publisher Site | Google Scholar
  248. M. Benhar, D. Engelberg, and A. Levitzki, “ROS, stress activated kinases and stress signaling in cancer,” EMBO Reports, vol. 34, pp. 420–425, 2002. View at: Google Scholar
  249. M. B. Reid, F. A. Khawli, and M. R. Moody, “Reactive oxygen in skeletal muscle. III. Contractility of unfatigued muscle,” Journal of Applied Physiology, vol. 75, no. 3, pp. 1081–1087, 1993. View at: Publisher Site | Google Scholar
  250. M. B. Reid and M. R. Moody, “Dimethyl sulfoxide depresses skeletal muscle contractility,” Journal of Applied Physiology, vol. 76, no. 5, pp. 2186–2190, 1994. View at: Publisher Site | Google Scholar
  251. M. S. Wolin, “Interactions of oxidants with vascular signaling systems,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 6, pp. 1430–1442, 2000. View at: Publisher Site | Google Scholar
  252. M. Pao, E. A. Wiggs, M. M. Anastacio et al., “Cognitive function in patients with chronic granulomatous disease: a preliminary report,” Psychosomatics, vol. 45, no. 3, pp. 230–234, 2004. View at: Publisher Site | Google Scholar
  253. D. Harman, “Origin and evolution of the free radical theory of aging: a brief personal history, 1954–2009,” Biogerontology, vol. 10, no. 6, pp. 773–781, 2009. View at: Publisher Site | Google Scholar
  254. M. Ristow and S. Schmeisser, “Extending life span by increasing oxidative stress,” Free Radical Biology & Medicine, vol. 51, no. 2, pp. 327–336, 2011. View at: Publisher Site | Google Scholar
  255. L. W. Oberley, D. K. S. Clair, A. P. Autor, and T. D. Oberley, “Increase in manganese superoxide dismutase activity in the mouse heart after X-irradiation,” Archives of Biochemistry and Biophysics, vol. 254, no. 1, pp. 69–80, 1987. View at: Publisher Site | Google Scholar
  256. R. Summers, B. Maves, R. Reeves, L. Arjes, and L. Oberley, “Irradiation increases superoxide dismutase in rat intestinal smooth muscle,” Free Radical Biology & Medicine, vol. 6, no. 3, pp. 261–270, 1989. View at: Publisher Site | Google Scholar
  257. H. M. Hassan and I. Fridovich, “Regulation of the synthesis of superoxide dismutase in Escherichia coli. Induction by methyl viologen,” Journal of Biological Chemistry, vol. 252, no. 21, pp. 7667–7672, 1977. View at: Google Scholar
  258. B. Demple and J. Halbrook, “Inducible repair of oxidative DNA damage in Escherichia coli,” Nature, vol. 304, no. 5925, pp. 466–468, 1983. View at: Publisher Site | Google Scholar
  259. E. Chan and B. Weiss, “Endonuclease IV of Escherichia coli is induced by paraquat,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 10, pp. 3189–3193, 1987. View at: Publisher Site | Google Scholar
  260. M. F. Christman, R. W. Morgan, F. S. Jacobson, and B. N. Ames, “Positive control of a regulon for defenses against oxidative stress and some heat-shock proteins in Salmonella typhimurium,” Cell, vol. 41, no. 3, pp. 753–762, 1985. View at: Publisher Site | Google Scholar
  261. I. R. Tsaneva and B. Weiss, “soxR, a locus governing a superoxide response regulon in Escherichia coli K-12,” Journal of Bacteriology, vol. 172, no. 8, pp. 4197–4205, 1990. View at: Publisher Site | Google Scholar
  262. J. T. Greenberg, P. Monach, J. H. Chou, P. D. Josephy, and B. Demple, “Positive control of a global antioxidant defense regulon activated by superoxide-generating agents in Escherichia coli,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 16, pp. 6181–6185, 1990. View at: Publisher Site | Google Scholar
  263. J. T. Greenberg and B. Demple, “A global response Induced in Escherichia coli by redox-cycling agents overlaps with that induced by peroxide stress,” Journal of Bacteriology, vol. 171, no. 7, pp. 3933–3939, 1989. View at: Publisher Site | Google Scholar
  264. J. G. Scandalios, “Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses,” Brazilian Journal of Medical and Biological Research, vol. 38, no. 7, pp. 995–1014, 2005. View at: Publisher Site | Google Scholar
  265. K. Itoh, T. Chiba, S. Takahashi et al., “An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements,” Biochemical and Biophysical Research Communications, vol. 236, no. 2, pp. 313–322, 1997. View at: Publisher Site | Google Scholar
  266. K. Itoh, N. Wakabayashi, Y. Katoh et al., “Keap 1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain,” Genes & Development, vol. 3, pp. 76–86, 1999. View at: Google Scholar
  267. P. D. Ray, B.-W. Huang, and Y. Tsuji, “Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling,” Cellular Signalling, vol. 24, no. 5, pp. 981–990, 2012. View at: Publisher Site | Google Scholar
  268. C. Bogdan, “Nitric oxide and the regulation of gene expression,” Trends in Cell Biology, vol. 11, no. 2, pp. 66–75, 2001. View at: Publisher Site | Google Scholar
  269. P. Pacher, J. S. Beckman, and L. Liaudet, “Nitric oxide and peroxynitrite in health and disease,” Physiological Reviews, vol. 87, pp. 315–424, 2007. View at: Google Scholar
  270. B. T. Mellion, L. J. Ignarro, E. H. Ohlstein, E. G. Pontecorvo, A. L. Hyman, and P. J. Kadowitz, “Evidence for the inhibitory role of guanosine 3, 5-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators,” Blood, vol. 57, no. 5, pp. 946–955, 1981. View at: Publisher Site | Google Scholar
  271. J. Garthwaite, S. L. Charles, and R. Chess-Williams, “Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain,” Nature (London), vol. 336, no. 6197, pp. 385–388, 1988. View at: Publisher Site | Google Scholar
  272. S. Moncada and A. Higgs, “The l-arginine-nitric oxide pathway,” The New England Journal of Medicine, vol. 329, no. 27, pp. 2002–2012, 1993. View at: Publisher Site | Google Scholar
  273. D. S. Bredt, P. M. Hwang, and S. H. Snyder, “Localization of nitric oxide synthase indicating a neural role for nitric oxide,” Nature, vol. 347, no. 6295, pp. 768–770, 1990. View at: Publisher Site | Google Scholar
  274. H. Rubbo, R. Radi, M. Trujillo et al., “Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives,” Journal of Biological Chemistry, vol. 269, no. 42, pp. 26066–26075, 1994. View at: Google Scholar
  275. C. Nathan, “Nitric oxide as a secretory product of mammalian cells,” The FASEB Journal, vol. 6, no. 12, pp. 3051–3064, 1992. View at: Publisher Site | Google Scholar
  276. C. S. Wilcox, W. J. Welch, F. Murad et al., “Nitric oxide synthase in macula densa regulates glomerular capillary pressure,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 24, pp. 11993–11997, 1992. View at: Publisher Site | Google Scholar
  277. J. D. MacMicking, C. Nathan, G. Hom et al., “Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase,” Cell, vol. 81, no. 4, pp. 641–650, 1995. View at: Publisher Site | Google Scholar
  278. A. J. Lambert and M. D. Brand, “Reactive oxygen species production by mitochondria,” Methods in Molecular Biology, vol. 554, pp. 165–181, 2009. View at: Publisher Site | Google Scholar
  279. D.-F. Dai, Y. Chiao, D. J. Marcinek, H. H. Szeto, and P. S. Rabinovitch, “Mitochondrial oxidative stress in aging and healthspan,” Longevity & Healthspan, vol. 3, no. 1, p. 6, 2014. View at: Publisher Site | Google Scholar
  280. N. A. Bonekamp, H. K. Delille, and M. Schrader, “Organelle dynamics and dysfunction: a closer link between peroxisomes and mitochondria,” Journal of Inherited Metabolic Disease, vol. 32, pp. 163–180, 2009. View at: Google Scholar
  281. K. Vannuvel, P. Renard, M. Raes, and T. Arnould, “Functional and morphological impact of ER stress on mitochondria,” Journal of Cellular Physiology, vol. 228, no. 9, pp. 1802–1818, 2013. View at: Publisher Site | Google Scholar
  282. L. L. Hilenski, R. E. Clempus, M. T. Quinn et al., “There is no evidence that mitochondria are the main source of reactive oxygen species in mammalian cells,” Mitochondrion, vol. 12, pp. 1–4, 2012. View at: Google Scholar
  283. F. Camões, “Nox 4 in vascular smooth muscle cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, pp. 677–683, 2004. View at: Google Scholar
  284. M. Ushio-Fukai, “Localizing NADPH oxidase–derived ROS,” Science’s STKE, vol. 2006, no. 349, p. re8, 2006. View at: Publisher Site | Google Scholar
  285. N. M. Mishina, P. A. Tyurin-Kuzmin, K. N. Markvicheva et al., “Does cellular hydrogen peroxide diffuse or act locally?” Antioxidants & Redox Signaling, vol. 14, no. 1, pp. 1–7, 2011. View at: Publisher Site | Google Scholar
  286. R. F. Wu, Z. Ma, Z. Liu, and L. S. Terada, “Nox4-derived H2O2 mediates endoplasmic reticulum signaling through local Ras activation,” Molecular and Cellular Biology, vol. 30, no. 14, pp. 3553–3568, 2010. View at: Publisher Site | Google Scholar
  287. C. C. Winterbourn, “Reconciling the chemistry and biology of reactive oxygen species,” Nature Chemical Biology, vol. 4, no. 5, pp. 278–286, 2008. View at: Publisher Site | Google Scholar
  288. F. Hutchinson, “The distance that a radical formed by ionizing radiation can diffuse in a yeast cell,” Radiation Research, vol. 7, no. 5, pp. 473–483, 1957. View at: Publisher Site | Google Scholar
  289. A. Friebe, G. Schultz, and D. Koesling, “Stimulation of soluble guanylate cyclase by superoxide dismutase is mediated by NO,” The Biochemical Journal, vol. 335, no. 3, pp. 527–531, 1998. View at: Publisher Site | Google Scholar
  290. R. Radi, “Protein tyrosine nitration: biochemical mechanisms and structural basis of functional effects,” Accounts of Chemical Research, vol. 46, no. 2, pp. 550–559, 2013. View at: Publisher Site | Google Scholar
  291. L. Liaudet, G. Vassalli, and P. Pacher, “Role of peroxynitrite in the redox regulation of cell signal transduction pathways,” Frontiers in Bioscience, vol. 14, pp. 4809–4814, 2009. View at: Google Scholar
  292. C. C. Winterbourn and D. Metodiewa, “[7] Reaction of superoxide with glutathioneand other thiols,” Methods in Enzymology, vol. 251, pp. 81–86, 1995. View at: Publisher Site | Google Scholar
  293. H. J. Forman and I. Fridovich, “Superoxide dismutase: a comparison of rate constants,” Archives of Biochemistry and Biophysics, vol. 158, no. 1, pp. 396–400, 1973. View at: Publisher Site | Google Scholar
  294. B. J. Hawkins, M. Madesh, C. J. Kirkpatrick, and A. B. Fisher, “Superoxide flux in endothelial cells via the chloride channel-3 mediates intracellular signaling,” Molecular Biology of the Cell, vol. 18, no. 6, pp. 2002–2012, 2007. View at: Publisher Site | Google Scholar
  295. V. J. Thannickal and B. L. Fanburg, “Reactive oxygen species in cell signaling,” American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 279, no. 6, pp. L1005–L1028, 2000. View at: Google Scholar
  296. J. M. Denu and K. G. Tanner, “Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation†,” Biochemistry, vol. 37, no. 16, pp. 5633–5642, 1998. View at: Publisher Site | Google Scholar
  297. M. Zheng, F. Åslund, and G. Storz, “Activation of the OxyR transcription factor by reversible disulfide bond formation,” Science, vol. 279, no. 5357, pp. 1718–1722, 1998. View at: Publisher Site | Google Scholar
  298. Y. Ji, T. P. M. Akerboom, H. Sies, and J. A. Thomas, “S-Nitrosylation and S-glutathiolation of protein sulfhydryls by S-nitroso glutathione,” Archives of Biochemistry and Biophysics, vol. 362, no. 1, pp. 67–78, 1999. View at: Publisher Site | Google Scholar
  299. G. Roos and J. Messens, “Protein sulfenic acid formation: from cellular damage to redox regulation,” Free Radical Biology & Medicine, vol. 51, no. 2, pp. 314–326, 2011. View at: Publisher Site | Google Scholar
  300. W. C. Barrett, J. P. DeGnore, Y. F. Keng, Z. Y. Zhang, M. B. Yim, and P. B. Chock, “Roles of superoxide radical anion in signal transduction mediated by reversible regulation of protein-tyrosine phosphatase 1B,” The Journal of Biological Chemistry, vol. 274, no. 49, pp. 34543–34546, 1999. View at: Publisher Site | Google Scholar
  301. C. Abate, L. Patel, F. Rauscher, and T. Curran, “Redox regulation of fos and jun DNA-binding activity in vitro,” Science, vol. 249, no. 4973, pp. 1157–1161, 1990. View at: Publisher Site | Google Scholar
  302. G. Filomeni, G. Rotilio, and M. R. Ciriolo, “Disulfide relays and phosphorylative cascades: partners in redox-mediated signaling pathways,” Cell Death and Differentiation, vol. 12, no. 12, pp. 1555–1563, 2005. View at: Publisher Site | Google Scholar
  303. Y. Gotoh and J. A. Cooper, “Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-alpha signal transduction,” The Journal of Biological Chemistry, vol. 273, no. 28, pp. 17477–17482, 1998. View at: Publisher Site | Google Scholar
  304. H. Ichijo, E. Nishida, K. Irie et al., “Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways,” Science, vol. 275, no. 5296, pp. 90–94, 1997. View at: Publisher Site | Google Scholar
  305. W. John, J. W. Denninger, and M. A. Marletta, “Guanylate cyclase and the ⋅NO/cGMP signaling pathway,” Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1411, no. 2-3, pp. 334–350, 1999. View at: Publisher Site | Google Scholar
  306. D. Salvemini, T. P. Misko, J. L. Masferrer, K. Seibert, M. G. Currie, and P. Needleman, “Nitric oxide activates cyclooxygenase enzymes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 15, pp. 7240–7244, 1993. View at: Publisher Site | Google Scholar
  307. G. C. Brown, “Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase,” FEBS Letters, vol. 369, no. 2-3, pp. 136–139, 1995. View at: Publisher Site | Google Scholar
  308. P. A. Erwin, D. A. Mitchell, J. Sartoretto, M. A. Marletta, and T. Michel, “Subcellular targeting and differential S-nitrosylation of endothelial nitric-oxide synthase,” The Journal of Biological Chemistry, vol. 281, no. 1, pp. 151–157, 2006. View at: Publisher Site | Google Scholar
  309. E. Clementi, G. C. Brown, M. Feelisch, and S. Moncada, “Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 13, pp. 7631–7636, 1998. View at: Publisher Site | Google Scholar
  310. R. Radi, “Nitric oxide, oxidants, and protein tyrosine nitration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 12, pp. 4003–4008, 2004. View at: Publisher Site | Google Scholar
  311. G. Peluffo and R. Radi, “Biochemistry of protein tyrosine nitration in cardiovascular pathology,” Cardiovascular Research, vol. 75, no. 2, pp. 291–302, 2007. View at: Publisher Site | Google Scholar
  312. H. Rubbo and R. Radi, “Protein and lipid nitration: role in redox signaling and injury,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1780, no. 11, pp. 1318–1324, 2008. View at: Publisher Site | Google Scholar
  313. J. M. Souza, G. Peluffo, and R. Radi, “Protein tyrosine nitration—functional alteration or just a biomarker?” Free Radical Biology & Medicine, vol. 45, no. 4, pp. 357–366, 2008. View at: Publisher Site | Google Scholar
  314. L. A. MacMillan-Crow, J. P. Crow, J. D. Kerby, J. S. Beckman, and J. A. Thompson, “Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 21, pp. 11853–11858, 1996. View at: Publisher Site | Google Scholar
  315. N. B. Surmeli, N. K. Litterman, A. F. Miller, and J. T. Groves, “Peroxynitrite mediates active site tyrosine nitration in manganese superoxide dismutase. Evidence of a role for the carbonate radical anion,” Journal of the American Chemical Society, vol. 132, no. 48, pp. 17174–17185, 2010. View at: Publisher Site | Google Scholar
  316. Y. Dündar and R. Aslan, “Antioxidative stress,” Eastern Journal of Medicine, vol. 5, no. 2, pp. 45–54, 2000. View at: Google Scholar
  317. W. B. Dunham, E. Zuckerkandl, R. Reynolds et al., “Effects of intake of L-ascorbic acid on the incidence of dermal neoplasms induced in mice by ultraviolet light,” Proceedings of the National Academy of Sciences of the United States of America, vol. 79, no. 23, pp. 7532–7536, 1982. View at: Publisher Site | Google Scholar
  318. L. Pauling, “Effect of ascorbic acid on incidence of spontaneous mammary tumors and UV-light-induced skin tumors in mice,” The American Journal of Clinical Nutrition, vol. 54, no. 6, pp. 1252S–1255S, 1991. View at: Publisher Site | Google Scholar
  319. G. Bjelakovic, D. Nikolova, L. L. Gluud, R. G. Simonetti, and C. Gluud, “Mortality in randomized trials of antioxidant supplements for primary and secondary prevention,” JAMA, vol. 297, no. 8, pp. 842–857, 2007. View at: Publisher Site | Google Scholar
  320. P. Aisen, G. Cohen, and J. O. Rang, “Iron toxicosis,” International Review of Experimental Pathology, vol. 31, pp. 1–46, 1990. View at: Publisher Site | Google Scholar
  321. V. Herbert, S. Shaw, E. Jayatilleke, and T. Stopler-Kasdan, “Most free-radical injury is iron-related: it is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin,” Stem Cells, vol. 12, no. 3, pp. 289–303, 1994. View at: Publisher Site | Google Scholar
  322. V. Herbert, “Megaloblastic anemia,” The New England Journal of Medicine, vol. 268, no. 7, pp. 368–371, 1963. View at: Publisher Site | Google Scholar
  323. V. Herbert, A. Cohen, and E. Schwartz, “Vitamin C and iron overload,” The New England Journal of Medicine, vol. 304, p. 1108, 1981. View at: Google Scholar
  324. C. J. McLaran, J. H. N. Bett, J. A. Nye, and J. W. Halliday, “Congestive cardiomyopathy and haemochromatosis- rapid progression possibly accelerated by excessive ingestion of ascorbic acid,” Australian and New Zealand Journal of Medicine, vol. 12, no. 2, pp. 187-188, 1982. View at: Publisher Site | Google Scholar
  325. V. Herbert, “Viewpoint does mega-C do more good than harm, or more harm than good?” Nutrition Today, vol. 28, no. 1, pp. 28–32, 1993. View at: Publisher Site | Google Scholar
  326. K. R. Martin and J. C. Barrett, “Reactive oxygen species as double-edged swords in cellular processes: low-dose cell signaling versus high-dose toxicity,” Human & Experimental Toxicology, vol. 21, no. 2, pp. 71–75, 2002. View at: Publisher Site | Google Scholar
  327. S. Di Meo, T. T. Reed, P. Venditti, and V. M. Victor, “Role of ROS and RNS sources in physiological and pathological conditions,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 1245049, 44 pages, 2016. View at: Publisher Site | Google Scholar
  328. D. E. R. Warburton, C. W. Nicol, and S. S. D. Bredin, “Health benefits of physical activity: the evidence,” Canadian Medical Association Journal, vol. 174, no. 6, pp. 801–809, 2006. View at: Publisher Site | Google Scholar
  329. B. K. Pedersen and B. Saltin, “Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases,” Scandinavian Journal of Medicine & Science in Sports, vol. 2, pp. 1–72, 2015. View at: Google Scholar
  330. C. B. Ebbeling and P. M. Clarkson, “Exercise-induced muscle damage and adaptation,” Sports Medicine, vol. 7, no. 4, pp. 207–234, 1989. View at: Publisher Site | Google Scholar
  331. P. Venditti and S. Di Meo, “Antioxidants, tissue damage, and endurance in trained and untrained young male rats,” Archives of Biochemistry and Biophysics, vol. 331, no. 1, pp. 63–68, 1996. View at: Publisher Site | Google Scholar
  332. P. Venditti and S. Di Meo, “Effect of training on antioxidant capacity, tissue damage, and endurance of adult male rats,” International Journal of Sports Medicine, vol. 1, pp. 497–502, 1997. View at: Google Scholar
  333. C. G. R. Perry, J. Lally, G. P. Holloway, G. J. F. Heigenhauser, A. Bonen, and L. L. Spriet, “Repeated transient mRNA bursts precede increases in transcriptional and mitochondrial proteins during training in human skeletal muscle,” The Journal of Physiology, vol. 588, no. 23, pp. 4795–4810, 2010. View at: Publisher Site | Google Scholar
  334. J. A. Hawley, “Adaptations of skeletal muscle to prolonged, intense endurance training,” Clinical and Experimental Pharmacology & Physiology, vol. 29, no. 3, pp. 218–222, 2002. View at: Publisher Site | Google Scholar
  335. S. Oh-Ishi, T. Kizaki, T. Ookawara et al., “Endurance training improves the resistance of rat diaphragm to exercise-induced oxidative stress,” American Journal of Respiratory and Critical Care Medicine, vol. 156, no. 5, pp. 1579–1585, 1997. View at: Publisher Site | Google Scholar
  336. Y. Maruhashi, K. Kitaoka, Y. Yoshiki et al., “ROS scavenging activity and muscle damage prevention in eccentric exercise in rats,” The Journal of Physiological Sciences, vol. 57, no. 4, pp. 211–216, 2007. View at: Publisher Site | Google Scholar
  337. P. Venditti, P. Masullo, and S. di Meo, “Effect of training on H2O2 release by mitochondria from rat skeletal muscle,” Archives of Biochemistry and Biophysics, vol. 372, no. 2, pp. 315–320, 1999. View at: Publisher Site | Google Scholar
  338. A. M. Molnar, S. Servais, M. Guichardant et al., “Mitochondrial H2O2 production is reduced with acute and chronic eccentric exercise in rat skeletal muscle,” Antioxidants & Redox Signaling, vol. 8, no. 3-4, pp. 548–558, 2006. View at: Publisher Site | Google Scholar
  339. M. C. Gomez-Cabrera, E. Domenech, and J. Viña, “Moderate exercise is an antioxidant: upregulation of antioxidant genes by training,” Free Radical Biology & Medicine, vol. 44, no. 2, pp. 126–131, 2008. View at: Publisher Site | Google Scholar
  340. M. G. Nikolaidis, C. M. Kerksick, M. Lamprecht, and S. R. McAnulty, “Does vitamin C and E supplementation impair the favorable adaptations of regular exercise?” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 707941, 11 pages, 2012. View at: Publisher Site | Google Scholar
  341. M. Ristow, K. Zarse, A. Oberbach et al., “Antioxidants prevent health-promoting effects of physical exercise in humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 21, pp. 8665–8670, 2009. View at: Publisher Site | Google Scholar
  342. T. L. Merry and M. Ristow, “Do antioxidant supplements interfere with skeletal muscle adaptation to exercise training?” Physiologie, vol. 594, no. 18, pp. 5135–5147, 2016. View at: Publisher Site | Google Scholar

Copyright © 2020 Sergio Di Meo and Paola Venditti. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.